AID,SERVICE_YEAR,QUALITY_SERVICE,Service,INDICATOR_ID,Ruleset,Care domain (CQRS short domain name),DPO_FLG,INDICATOR_TYPE,INDICATOR_ID,INDICATOR_DESCRIPTION,MEASURE_TYPE,MEASURE,MEASURE_DESCRIPTION,DPO,DPO_DESCRIPTION,DPO_BREAKDOWN,CQRS short code
tbc,2023-24,NCD,NCD,NCD003,Vaccination & Immunisation,NCD,0,FI,NCD003,Percentage of at-risk patients aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March.,Exclusion,N_AT_RISK,N_AT_RISK,n/a,n/a,n/a,N_AT_RISK
tbc,2023-24,NCD,NCD,NCD003,Vaccination & Immunisation,NCD,0,FI,NCD003,Percentage of at-risk patients aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD004,Vaccination & Immunisation,NCD,0,FI,NCD004,Percentage of patients aged two or three years on 31 August of the relevant financial year who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUINVITE1,FLUINVITE1,n/a,n/a,n/a,FLUINVITE1
tbc,2023-24,NCD,NCD,NCD004,Vaccination & Immunisation,NCD,0,FI,NCD004,Percentage of patients aged two or three years on 31 August of the relevant financial year who received a seasonal influenza vaccination between 1 September and 31 March.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD011,Cardiovascular Disease Prevention,NCD,0,FI,NCD011,"Percentage of patients aged 18 years or over, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90mmHg (with the exception of patients whose first blood pressure reading >= 140/90mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD026,Access,NCD,0,FI,NCD026,Percentage of appointments where time from booking to appointment was two weeks or less,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD111,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD111,"Percentage of patients prescribed a direct-acting oral anticoagulant, who received a renal function test and a recording of their weight and Creatinine Clearance Rate, along with a change or confirmation of their medication dose.",Exclusion,L12MNODOAC,L12MNODOAC,n/a,n/a,n/a,L12MNODOAC
tbc,2023-24,NCD,NCD,NCD111,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD111,"Percentage of patients prescribed a direct-acting oral anticoagulant, who received a renal function test and a recording of their weight and Creatinine Clearance Rate, along with a change or confirmation of their medication dose.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD111,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD111,"Percentage of patients prescribed a direct-acting oral anticoagulant, who received a renal function test and a recording of their weight and Creatinine Clearance Rate, along with a change or confirmation of their medication dose.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD117,Cardiovascular Disease Prevention,NCD,0,FI,NCD117,"Percentage of men aged 50 years or over and women aged 55 years or over, without established Cardiovascular Disease and not on lipid lowering therapy, who have a QRISK score recorded on their GP record in the preceding five years and who have a recording of cholesterol levels, blood pressure and smoking status in the 12 months preceding recording of the most recent QRISK score",Exclusion,PALCARE,PALCARE,n/a,n/a,n/a,PALCARE
tbc,2023-24,NCD,NCD,NCD120,Tackling Health Inequalities,NCD,0,FI,NCD120,"Percentage of patients on the QOF Learning Disability register aged 14 or over, who received an annual Learning Disability Health Check and have a completed Health Action Plan, in addition to a recording of ethnicity.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD121,Cardiovascular Disease Prevention,NCD,0,FI,NCD121,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease or diabetes and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins, or where a statin is declined or clinically unsuitable, another lipid-lowering therapy.",Exclusion,DIABUNRES,DIABUNRES,n/a,n/a,n/a,DIABUNRES
tbc,2023-24,NCD,NCD,NCD121,Cardiovascular Disease Prevention,NCD,0,FI,NCD121,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease or diabetes and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins, or where a statin is declined or clinically unsuitable, another lipid-lowering therapy.",Exclusion,P_AGE25_84,P_AGE25_84,n/a,n/a,n/a,P_AGE25_84
tbc,2023-24,NCD,NCD,NCDMI010,Enhanced Health in Care Homes,NCD,0,FI,NCDMI010,"Percentage of permanent care home residents aged 18 years or over, and recorded as experiencing acute confusion, who received a delirium assessment.",PCA,CARHOMDEC1,CARHOMDEC1,n/a,n/a,n/a,CARHOMDEC1
tbc,2023-24,NCD,NCD,NCDMI027,Vaccination & Immunisation,NCD,0,FI,NCDMI027,"Percentage of patients on the QOF Mental Health register for schizophrenia, bipolar affective disorder and other psychoses and either aged 65 years or over, or aged between 18 and 64 years inclusive and in a clinical at-risk group, who received a seasonal influenza vaccination between 1 September and 31 March.",PCA,FLUINVITE1,FLUINVITE1,n/a,n/a,n/a,FLUINVITE1
tbc,2023-24,NCD,NCD,NCDMI027,Vaccination & Immunisation,NCD,0,FI,NCDMI027,"Percentage of patients on the QOF Mental Health register for schizophrenia, bipolar affective disorder and other psychoses and either aged 65 years or over, or aged between 18 and 64 years inclusive and in a clinical at-risk group, who received a seasonal influenza vaccination between 1 September and 31 March.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI061,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI061,"Percentage of patients aged 25 to 84 years inclusive and with a last recorded CVD risk score (QRISK2 or 3) greater than or equal to 10 percent, who are currently treated with statins.",Exclusion,CVDPAL_DAT,CVDPAL_DAT,n/a,n/a,n/a,CVDPAL_DAT
tbc,2023-24,NCD,NCD,NCDMI101,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI101,"Percentage of patients aged 65 years or over and who received a blood pressure check, who received a pulse check",Exclusion,UNRESAFIB,UNRESAFIB,n/a,n/a,n/a,UNRESAFIB
tbc,2023-24,NCD,NCD,NCDMI112,Enhanced Health in Care Homes,NCD,0,FI,NCDMI112,Percentage of care home residents aged 18 years or over on the QOF Dementia Register.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI113,Enhanced Health in Care Homes,NCD,0,FI,NCDMI113,Percentage of permanent care home residents aged 18 years or over with a preferred place of death recorded.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI117,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI117,"Percentage of patients aged 18 years or over with a history of peptic ulceration and prescribed an oral non-steroidal anti-inflammatory drug (NSAID), who were not prescribed a gastro-protective.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI118,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI118,"Percentage of patients aged 18 years or over with a history of peptic ulceration and prescribed an anti-platelet, who were not prescribed a gastro-protective",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI119,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI119,"Percentage of patients aged 18 years or over prescribed an oral anticoagulant, who were prescribed an oral NSAID.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI121,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI121,"Percentage of patients aged 18 years or over prescribed aspirin and another anti-platelet, who were not prescribed a gastro-protective.",Exclusion,ASPIRIN3M,ASPIRIN3M,n/a,n/a,n/a,ASPIRIN3M
tbc,2023-24,NCD,NCD,NCDMI123,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI123,Percentage of patients aged 18 years or over with an eGFR less than 45 who were prescribed an oral non-steroidal anti-inflammatory drug (NSAID).,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI124,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI124,Percentage of patients aged 18 years or over with an unresolved asthma diagnosis who were prescribed a non-selective beta-blocker.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI124,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI124,Percentage of patients aged 18 years or over with an unresolved asthma diagnosis who were prescribed a non-selective beta-blocker.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI125,Anticipatory Care,NCD,0,FI,NCDMI125,Percentage of registered patients under the care of Anticipatory Care service,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI126,Anticipatory Care,NCD,0,FI,NCDMI126,Percentage of registered patients who declined an offer of Anticipatory Care,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI127,Anticipatory Care,NCD,0,FI,NCDMI127,Percentage of registered patients discharged from Anticipatory Care service,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI129,Tackling Health Inequalities,NCD,0,FI,NCDMI129,Percentage of at-risk patients recorded as being from an ethnic minority and aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March,Exclusion,N_AT_RISK,N_AT_RISK,n/a,n/a,n/a,N_AT_RISK
tbc,2023-24,NCD,NCD,NCDMI130,Tackling Health Inequalities,NCD,0,FI,NCDMI130,Percentage of patients aged 16 years or over who have received a second dose of a Covid 19 vaccination,PCA,C19DEC_DAT,C19DEC_DAT,n/a,n/a,n/a,C19DEC_DAT
tbc,2023-24,NCD,NCD,NCDMI131,Tackling Health Inequalities,NCD,0,FI,NCDMI131,Percentage of patients aged 16 years or over and recorded as being from an ethnic minority who have received a second dose of a Covid 19 vaccination,Exclusion,PAT_AGEU16,PAT_AGEU16,n/a,n/a,n/a,PAT_AGEU16
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",PCA,PALCARDAT2,PALCARDAT2,n/a,n/a,n/a,PALCARDAT2
tbc,2023-24,NCD,NCD,NCDMI133,Tackling Health Inequalities,NCD,0,FI,NCDMI133,Percentage of patients aged 45 or over and recorded as being from an ethnic minority who have a record of blood pressure in the preceding 5 years,PCA,BPDEC1,BPDEC1,n/a,n/a,n/a,BPDEC1
tbc,2023-24,NCD,NCD,NCDMI133,Tackling Health Inequalities,NCD,0,FI,NCDMI133,Percentage of patients aged 45 or over and recorded as being from an ethnic minority who have a record of blood pressure in the preceding 5 years,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI135,Tackling Health Inequalities,NCD,0,FI,NCDMI135,"Percentage of patients with schizophrenia, bipolar affective disorder and other psychoses and recorded as being from an ethnic minority who received all six elements of the Physical Health Check for people with Severe Mental Illness",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI135,Tackling Health Inequalities,NCD,0,FI,NCDMI135,"Percentage of patients with schizophrenia, bipolar affective disorder and other psychoses and recorded as being from an ethnic minority who received all six elements of the Physical Health Check for people with Severe Mental Illness",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI147,Workforce,NCD,0,FI,NCDMI147,Percentage of registered patients who had at least one encounter with a Podiatrist.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI149,Workforce,NCD,0,FI,NCDMI149,Percentage of registered patients who had at least one encounter with a Pharmacy Technician.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI153,Workforce,NCD,0,FI,NCDMI153,Percentage of registered patients who had at least one encounter with a Social Prescribing Link Worker.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI157,Workforce,NCD,0,FI,NCDMI157,Percentage of registered patients who had at least one encounter with a Care Coordinator.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI159,Workforce,NCD,0,FI,NCDMI159,Percentage of registered patients who had at least one encounter with a Trainee Nursing Associate.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI162,Workforce,NCD,0,FI,NCDMI162,"Number of encounters with a Paramedic, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI165,Workforce,NCD,0,FI,NCDMI165,Percentage of registered patients who had at least one encounter with a Mental Health Practitioner.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI166,Access,NCD,0,FI,NCDMI166,Number of declined referrals to the Community Pharmacy Consultation Service per registered patient,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI170,Enhanced Health in Care Homes,NCD,0,FI,NCDMI170,Percentage of permanent care home residents aged 18 years or over who received a psychosocial assessment,Exclusion,LATNURSPER,LATNURSPER,n/a,n/a,n/a,LATNURSPER
tbc,2023-24,NCD,NCD,NCDMI172,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI172,Percentage of patients aged 18 years or over prescribed methotrexate for at least 3 months without a full blood count in the previous 3 months.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI173,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI173,Percentage of patients aged 18 years or over prescribed methotrexate for at least 3 months without a liver function test in the previous 3 months.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI174,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI174,Percentage of patients aged 18 years or over prescribed lithium for at least 3 months without a lithium concentration check in the previous 3 months.,Exclusion,NOLIT3M6M,NOLIT3M6M,n/a,n/a,n/a,NOLIT3M6M
tbc,2023-24,NCD,NCD,NCDMI174,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI174,Percentage of patients aged 18 years or over prescribed lithium for at least 3 months without a lithium concentration check in the previous 3 months.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI175,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI175,Percentage of patients aged 18 years or over prescribed amiodarone for at least 6 months without a thyroid function test (TFT) in the previous 6 months.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI176,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI176,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins.",Exclusion,QRISKVAL20,QRISKVAL20,n/a,n/a,n/a,QRISKVAL20
tbc,2023-24,NCD,NCD,NCDMI177,Respiratory Care,NCD,0,FI,NCDMI177,"Percentage of patients on the QOF Asthma Register who received three or more inhaled corticosteroid (ICS, inclusive of ICS/LABA) prescriptions over the previous 12 months.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI181,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI181,Percentage of patients living with severe frailty who received a Structured Medication Review.,Exclusion,SEVFRAIL2,SEVFRAIL2,n/a,n/a,n/a,SEVFRAIL2
tbc,2023-24,NCD,NCD,NCDMI182,Tackling Health Inequalities,NCD,0,FI,NCDMI182,"Percentage of patients on the QOF Learning Disability register aged 14 years or over, who received an annual Learning Disability Health Check and a completed Health Action Plan.",PCA,HLTHAPDEC,HLTHAPDEC,n/a,n/a,n/a,HLTHAPDEC
tbc,2023-24,NCD,NCD,NCDMI182,Tackling Health Inequalities,NCD,0,FI,NCDMI182,"Percentage of patients on the QOF Learning Disability register aged 14 years or over, who received an annual Learning Disability Health Check and a completed Health Action Plan.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI198,Enhanced Health in Care Homes,NCD,0,FI,NCDMI198,Mean number of patient contacts as part of weekly care home round per care home resident aged 18 years and over.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI198,Enhanced Health in Care Homes,NCD,0,FI,NCDMI198,Mean number of patient contacts as part of weekly care home round per care home resident aged 18 years and over.,Exclusion,NURSHOME,NURSHOME,n/a,n/a,n/a,NURSHOME
tbc,2023-24,NCD,NCD,NCD001,Personalised Care,NCD,0,FI,NCD001,Percentage of registered patients referred to a social prescribing service.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD001,Personalised Care,NCD,0,FI,NCD001,Percentage of registered patients referred to a social prescribing service.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD003,Vaccination & Immunisation,NCD,0,FI,NCD003,Percentage of at-risk patients aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUINVITE1,FLUINVITE1,n/a,n/a,n/a,FLUINVITE1
tbc,2023-24,NCD,NCD,NCD003,Vaccination & Immunisation,NCD,0,FI,NCD003,Percentage of at-risk patients aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March.,Exclusion,P_AGE18_64,P_AGE18_64,n/a,n/a,n/a,P_AGE18_64
tbc,2023-24,NCD,NCD,NCD004,Vaccination & Immunisation,NCD,0,FI,NCD004,Percentage of patients aged two or three years on 31 August of the relevant financial year who received a seasonal influenza vaccination between 1 September and 31 March.,Exclusion,P_AGE2_4,P_AGE2_4,n/a,n/a,n/a,P_AGE2_4
tbc,2023-24,NCD,NCD,NCD011,Cardiovascular Disease Prevention,NCD,0,FI,NCD011,"Percentage of patients aged 18 years or over, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90mmHg (with the exception of patients whose first blood pressure reading >= 140/90mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",PCA,BPLAT6M,BPLAT6M,n/a,n/a,n/a,BPLAT6M
tbc,2023-24,NCD,NCD,NCD018,Enhanced Health in Care Homes,NCD,0,FI,NCD018,"Percentage of care home residents aged 18 years or over, who had a Personalised Care and Support Plan agreed or reviewed.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD018,Enhanced Health in Care Homes,NCD,0,FI,NCD018,"Percentage of care home residents aged 18 years or over, who had a Personalised Care and Support Plan agreed or reviewed.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD107,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD107,"Percentage of patients aged 18 years or over prescribed both a Non-Steroidal Anti-Inflammatory Drug (NSAID) and an oral anticoagulant in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an NSAID or (ii) prescribed a gastro-protective in addition to an NSAID.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD109,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD109,"Percentage of patients aged 18 years or over prescribed both an oral anticoagulant and an anti-platelet in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an anti-platelet or (ii) prescribed a gastro-protective in addition to an anti-platelet.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD112,Cancer,NCD,0,FI,NCD112,"Percentage of lower gastrointestinal two week wait (fast track) cancer referrals accompanied by a faecal immunochemical test result, with the result recorded either in the twenty-one days leading up to the referral, or in the fourteen days after the referral.",PCA,FAECIMMDEC,FAECIMMDEC,n/a,n/a,n/a,FAECIMMDEC
tbc,2023-24,NCD,NCD,NCD112,Cancer,NCD,0,FI,NCD112,"Percentage of lower gastrointestinal two week wait (fast track) cancer referrals accompanied by a faecal immunochemical test result, with the result recorded either in the twenty-one days leading up to the referral, or in the fourteen days after the referral.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD117,Cardiovascular Disease Prevention,NCD,0,FI,NCD117,"Percentage of men aged 50 years or over and women aged 55 years or over, without established Cardiovascular Disease and not on lipid lowering therapy, who have a QRISK score recorded on their GP record in the preceding five years and who have a recording of cholesterol levels, blood pressure and smoking status in the 12 months preceding recording of the most recent QRISK score",Exclusion,CVDDIAG,CVDDIAG,n/a,n/a,n/a,CVDDIAG
tbc,2023-24,NCD,NCD,NCD121,Cardiovascular Disease Prevention,NCD,0,FI,NCD121,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease or diabetes and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins, or where a statin is declined or clinically unsuitable, another lipid-lowering therapy.",PCA,PALCARDAT2,PALCARDAT2,n/a,n/a,n/a,PALCARDAT2
tbc,2023-24,NCD,NCD,NCD121,Cardiovascular Disease Prevention,NCD,0,FI,NCD121,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease or diabetes and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins, or where a statin is declined or clinically unsuitable, another lipid-lowering therapy.",Exclusion,QRISKVAL20,QRISKVAL20,n/a,n/a,n/a,QRISKVAL20
tbc,2023-24,NCD,NCD,NCDMI001,Personalised Care,NCD,0,FI,NCDMI001,Percentage of registered patients who had a Personalised Care and Support Plan agreed.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI001,Personalised Care,NCD,0,FI,NCDMI001,Percentage of registered patients who had a Personalised Care and Support Plan agreed.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI025,Vaccination & Immunisation,NCD,0,FI,NCDMI025,Percentage of patients in long stay residential or homes who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUDEC_DAT,FLUDEC_DAT,n/a,n/a,n/a,FLUDEC_DAT
tbc,2023-24,NCD,NCD,NCDMI025,Vaccination & Immunisation,NCD,0,FI,NCDMI025,Percentage of patients in long stay residential or homes who received a seasonal influenza vaccination between 1 September and 31 March.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI026,Vaccination & Immunisation,NCD,0,FI,NCDMI026,Percentage of patients on the Learning Disability register aged 18 years or over who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUINVITE1,FLUINVITE1,n/a,n/a,n/a,FLUINVITE1
tbc,2023-24,NCD,NCD,NCDMI027,Vaccination & Immunisation,NCD,0,FI,NCDMI027,"Percentage of patients on the QOF Mental Health register for schizophrenia, bipolar affective disorder and other psychoses and either aged 65 years or over, or aged between 18 and 64 years inclusive and in a clinical at-risk group, who received a seasonal influenza vaccination between 1 September and 31 March.",PCA,FLUDEC_DAT,FLUDEC_DAT,n/a,n/a,n/a,FLUDEC_DAT
tbc,2023-24,NCD,NCD,NCDMI027,Vaccination & Immunisation,NCD,0,FI,NCDMI027,"Percentage of patients on the QOF Mental Health register for schizophrenia, bipolar affective disorder and other psychoses and either aged 65 years or over, or aged between 18 and 64 years inclusive and in a clinical at-risk group, who received a seasonal influenza vaccination between 1 September and 31 March.",PCA,FLUEXPCON,FLUEXPCON,n/a,n/a,n/a,FLUEXPCON
tbc,2023-24,NCD,NCD,NCDMI061,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI061,"Percentage of patients aged 25 to 84 years inclusive and with a last recorded CVD risk score (QRISK2 or 3) greater than or equal to 10 percent, who are currently treated with statins.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI061,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI061,"Percentage of patients aged 25 to 84 years inclusive and with a last recorded CVD risk score (QRISK2 or 3) greater than or equal to 10 percent, who are currently treated with statins.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI089,Environmental Sustainability,NCD,0,FI,NCDMI089,Percentage of salbutamol inhaler prescriptions that are lower carbon.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI102,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI102,"Percentage of patients aged 18 years or over with an observation indicating suspected atrial fibrillation recorded during the financial year (including presentations of breathlessness, palpitations, syncope or dizziness, or chest discomfort) who received a pulse check.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI113,Enhanced Health in Care Homes,NCD,0,FI,NCDMI113,Percentage of permanent care home residents aged 18 years or over with a preferred place of death recorded.,Exclusion,LATNURSPER,LATNURSPER,n/a,n/a,n/a,LATNURSPER
tbc,2023-24,NCD,NCD,NCDMI113,Enhanced Health in Care Homes,NCD,0,FI,NCDMI113,Percentage of permanent care home residents aged 18 years or over with a preferred place of death recorded.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI114,Enhanced Health in Care Homes,NCD,0,FI,NCDMI114,Mean number of Multidisciplinary Team meetings per care home resident aged 18 years or over.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI116,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI116,"Percentage of patients aged 65 years or over prescribed an oral non-steroidal anti-inflammatory drug (NSAID), who were not prescribed a gastro-protective",Exclusion,NONSAID3M,NONSAID3M,n/a,n/a,n/a,NONSAID3M
tbc,2023-24,NCD,NCD,NCDMI119,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI119,"Percentage of patients aged 18 years or over prescribed an oral anticoagulant, who were prescribed an oral NSAID.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI120,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI120,"Percentage of patients aged 18 years or over prescribed an oral anticoagulant and an anti-platelet, who were not prescribed a gastro-protective.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI131,Tackling Health Inequalities,NCD,0,FI,NCDMI131,Percentage of patients aged 16 years or over and recorded as being from an ethnic minority who have received a second dose of a Covid 19 vaccination,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI131,Tackling Health Inequalities,NCD,0,FI,NCDMI131,Percentage of patients aged 16 years or over and recorded as being from an ethnic minority who have received a second dose of a Covid 19 vaccination,Exclusion,PAT_ETHWNS,PAT_ETHWNS,n/a,n/a,n/a,PAT_ETHWNS
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",PCA,ABPDEC24M,ABPDEC24M,n/a,n/a,n/a,ABPDEC24M
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Exclusion,BPLAT_2,BPLAT_2,n/a,n/a,n/a,BPLAT_2
tbc,2023-24,NCD,NCD,NCDMI133,Tackling Health Inequalities,NCD,0,FI,NCDMI133,Percentage of patients aged 45 or over and recorded as being from an ethnic minority who have a record of blood pressure in the preceding 5 years,Exclusion,PAT_ETHWNS,PAT_ETHWNS,n/a,n/a,n/a,PAT_ETHWNS
tbc,2023-24,NCD,NCD,NCDMI141,Workforce,NCD,0,FI,NCDMI141,Percentage of registered patients who had at least one encounter with a First Contact Physiotherapist.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI148,Workforce,NCD,0,FI,NCDMI148,"Number of encounters with a Pharmacy Technician, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI152,Workforce,NCD,0,FI,NCDMI152,"Number of encounters with a Social Prescribing Link Worker, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI158,Workforce,NCD,0,FI,NCDMI158,"Number of encounters with a Trainee Nursing Associate, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI173,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI173,Percentage of patients aged 18 years or over prescribed methotrexate for at least 3 months without a liver function test in the previous 3 months.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI174,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI174,Percentage of patients aged 18 years or over prescribed lithium for at least 3 months without a lithium concentration check in the previous 3 months.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI175,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI175,Percentage of patients aged 18 years or over prescribed amiodarone for at least 6 months without a thyroid function test (TFT) in the previous 6 months.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI176,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI176,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins.",PCA,CHOLMX_DAT,CHOLMX_DAT,n/a,n/a,n/a,CHOLMX_DAT
tbc,2023-24,NCD,NCD,NCDMI176,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI176,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins.",PCA,STATINTOL,STATINTOL,n/a,n/a,n/a,STATINTOL
tbc,2023-24,NCD,NCD,NCDMI177,Respiratory Care,NCD,0,FI,NCDMI177,"Percentage of patients on the QOF Asthma Register who received three or more inhaled corticosteroid (ICS, inclusive of ICS/LABA) prescriptions over the previous 12 months.",Exclusion,ASTRES_DAT,ASTRES_DAT,n/a,n/a,n/a,ASTRES_DAT
tbc,2023-24,NCD,NCD,NCDMI180,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI180,Percentage of patients at risk of harm due to medication errors who received a Structured Medication Review.,PCA,PALCARDAT2,PALCARDAT2,n/a,n/a,n/a,PALCARDAT2
tbc,2023-24,NCD,NCD,NCDMI181,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI181,Percentage of patients living with severe frailty who received a Structured Medication Review.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI188,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI188,Percentage of patients using potentially addictive medicines who received a Structured Medication Review.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI188,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI188,Percentage of patients using potentially addictive medicines who received a Structured Medication Review.,PCA,STRMEDRVDC,STRMEDRVDC,n/a,n/a,n/a,STRMEDRVDC
tbc,2023-24,NCD,NCD,NCDMI198,Enhanced Health in Care Homes,NCD,0,FI,NCDMI198,Mean number of patient contacts as part of weekly care home round per care home resident aged 18 years and over.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI198,Enhanced Health in Care Homes,NCD,0,FI,NCDMI198,Mean number of patient contacts as part of weekly care home round per care home resident aged 18 years and over.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI205,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI205,"Percentage of patients on the QOF Coronary Heart Disease, Peripheral Arterial Disease, or Stroke/TIA Register, who have a recording of non-HDL cholesterol in the preceding 12 months that is lower than 2.5 mmol/L, or where non-HDL cholesterol is not recorded then  a recording of LDL cholesterol in the preceding 12 months that is lower than 1.8 mmol/L.",Exclusion,NOCVDDIAG,NOCVDDIAG,n/a,n/a,n/a,NOCVDDIAG
tbc,2023-24,NCD,NCD,NCDMI205,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI205,"Percentage of patients on the QOF Coronary Heart Disease, Peripheral Arterial Disease, or Stroke/TIA Register, who have a recording of non-HDL cholesterol in the preceding 12 months that is lower than 2.5 mmol/L, or where non-HDL cholesterol is not recorded then  a recording of LDL cholesterol in the preceding 12 months that is lower than 1.8 mmol/L.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD102,Cardiovascular Disease Prevention,NCD,0,FI,NCD102,Percentage of patients aged 29 and under with a total cholesterol greater than 7.5mmol/L OR aged 30 and over with a total cholesterol greater than 9.0mmol/L who have been either: (i) diagnosed with secondary hyperlipidaemia; (ii) clinically assessed for familial hypercholesterolaemia; (iii) referred for assessment for familial hypercholesterolemia; or (iv) genetically diagnosed with familial hypercholesterolaemia.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD110,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD110,"Percentage of patients aged 18 years or over prescribed aspirin and another anti-platelet in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed aspirin and/or no longer prescribed an anti-platelet or (ii) prescribed a gastro-protective in addition to both aspirin and another anti-platelet.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD123,Cancer,NCD,0,FI,NCD123,"Percentage of lower gastrointestinal two week wait (fast track) cancer referrals accompanied by a faecal immunochemical test result, with the result recorded in the twenty-one days leading up to the referral.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI010,Enhanced Health in Care Homes,NCD,0,FI,NCDMI010,"Percentage of permanent care home residents aged 18 years or over, and recorded as experiencing acute confusion, who received a delirium assessment.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI024,Early Cancer Diagnosis,NCD,0,FI,NCDMI024,Percentage of patients placed on an urgent referral pathway for suspected cancer where safety netting was recorded.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI061,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI061,"Percentage of patients aged 25 to 84 years inclusive and with a last recorded CVD risk score (QRISK2 or 3) greater than or equal to 10 percent, who are currently treated with statins.",PCA,XSTAT_DAT,XSTAT_DAT,n/a,n/a,n/a,XSTAT_DAT
tbc,2023-24,NCD,NCD,NCDMI068,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI068,Mean number of structured medication reviews undertaken per registered patient.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI075,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI075,Percentage of registered patients prescribed antimicrobials.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI075,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI075,Percentage of registered patients prescribed antimicrobials.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI076,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI076,Percentage of registered patients prescribed benzodiazepines.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI102,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI102,"Percentage of patients aged 18 years or over with an observation indicating suspected atrial fibrillation recorded during the financial year (including presentations of breathlessness, palpitations, syncope or dizziness, or chest discomfort) who received a pulse check.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI110,Personalised Care,NCD,0,FI,NCDMI110,Number of consultations per registered patient.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI112,Enhanced Health in Care Homes,NCD,0,FI,NCDMI112,Percentage of care home residents aged 18 years or over on the QOF Dementia Register.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI116,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI116,"Percentage of patients aged 65 years or over prescribed an oral non-steroidal anti-inflammatory drug (NSAID), who were not prescribed a gastro-protective",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI118,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI118,"Percentage of patients aged 18 years or over with a history of peptic ulceration and prescribed an anti-platelet, who were not prescribed a gastro-protective",Exclusion,NOANTIPLT,NOANTIPLT,n/a,n/a,n/a,NOANTIPLT
tbc,2023-24,NCD,NCD,NCDMI124,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI124,Percentage of patients aged 18 years or over with an unresolved asthma diagnosis who were prescribed a non-selective beta-blocker.,Exclusion,ASTRESLAT,ASTRESLAT,n/a,n/a,n/a,ASTRESLAT
tbc,2023-24,NCD,NCD,NCDMI129,Tackling Health Inequalities,NCD,0,FI,NCDMI129,Percentage of at-risk patients recorded as being from an ethnic minority and aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March,PCA,FLUDEC_DAT,FLUDEC_DAT,n/a,n/a,n/a,FLUDEC_DAT
tbc,2023-24,NCD,NCD,NCDMI130,Tackling Health Inequalities,NCD,0,FI,NCDMI130,Percentage of patients aged 16 years or over who have received a second dose of a Covid 19 vaccination,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI138,Workforce,NCD,0,FI,NCDMI138,"Number of encounters with a Clinical Pharmacist, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI139,Workforce,NCD,0,FI,NCDMI139,Percentage of registered patients who had at least one encounter with a Clinical Pharmacist.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI144,Workforce,NCD,0,FI,NCDMI144,"Number of encounters with a Dietitian, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI144,Workforce,NCD,0,FI,NCDMI144,"Number of encounters with a Dietitian, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI145,Workforce,NCD,0,FI,NCDMI145,Percentage of registered patients who had at least one encounter with a Dietitian.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI161,Workforce,NCD,0,FI,NCDMI161,Percentage of registered patients who had at least one encounter with a Nursing Associate.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI164,Workforce,NCD,0,FI,NCDMI164,"Number of encounters with a Mental Health Practitioner, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI170,Enhanced Health in Care Homes,NCD,0,FI,NCDMI170,Percentage of permanent care home residents aged 18 years or over who received a psychosocial assessment,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI171,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI171,Percentage of patients aged 75 years or over on a long-term prescription of an angiotensin converting enzyme (ACE) inhibitor or a loop diuretic who have not had their renal function and electrolytes recorded in the previous 15 months.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI173,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI173,Percentage of patients aged 18 years or over prescribed methotrexate for at least 3 months without a liver function test in the previous 3 months.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI176,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI176,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI176,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI176,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI176,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI176,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins.",PCA,XSTAT_DAT,XSTAT_DAT,n/a,n/a,n/a,XSTAT_DAT
tbc,2023-24,NCD,NCD,NCDMI181,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI181,Percentage of patients living with severe frailty who received a Structured Medication Review.,PCA,STRMEDRVDC,STRMEDRVDC,n/a,n/a,n/a,STRMEDRVDC
tbc,2023-24,NCD,NCD,NCDMI205,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI205,"Percentage of patients on the QOF Coronary Heart Disease, Peripheral Arterial Disease, or Stroke/TIA Register, who have a recording of non-HDL cholesterol in the preceding 12 months that is lower than 2.5 mmol/L, or where non-HDL cholesterol is not recorded then  a recording of LDL cholesterol in the preceding 12 months that is lower than 1.8 mmol/L.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD001,Personalised Care,NCD,0,FI,NCD001,Percentage of registered patients referred to a social prescribing service.,PCA,SOCPRESDEC,SOCPRESDEC,n/a,n/a,n/a,SOCPRESDEC
tbc,2023-24,NCD,NCD,NCD004,Vaccination & Immunisation,NCD,0,FI,NCD004,Percentage of patients aged two or three years on 31 August of the relevant financial year who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUEXPCON,FLUEXPCON,n/a,n/a,n/a,FLUEXPCON
tbc,2023-24,NCD,NCD,NCD011,Cardiovascular Disease Prevention,NCD,0,FI,NCD011,"Percentage of patients aged 18 years or over, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90mmHg (with the exception of patients whose first blood pressure reading >= 140/90mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Exclusion,BPLAT_2,BPLAT_2,n/a,n/a,n/a,BPLAT_2
tbc,2023-24,NCD,NCD,NCD012,Enhanced Health in Care Homes,NCD,0,FI,NCD012,"Number of patients aged 18 years or over and recorded as living in a care home, as a percentage of care home beds eligible to receive the Enhanced Health in Care Homes service",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD012,Enhanced Health in Care Homes,NCD,0,FI,NCD012,"Number of patients aged 18 years or over and recorded as living in a care home, as a percentage of care home beds eligible to receive the Enhanced Health in Care Homes service",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD018,Enhanced Health in Care Homes,NCD,0,FI,NCD018,"Percentage of care home residents aged 18 years or over, who had a Personalised Care and Support Plan agreed or reviewed.",PCA,CARHOMDEC1,CARHOMDEC1,n/a,n/a,n/a,CARHOMDEC1
tbc,2023-24,NCD,NCD,NCD102,Cardiovascular Disease Prevention,NCD,0,FI,NCD102,Percentage of patients aged 29 and under with a total cholesterol greater than 7.5mmol/L OR aged 30 and over with a total cholesterol greater than 9.0mmol/L who have been either: (i) diagnosed with secondary hyperlipidaemia; (ii) clinically assessed for familial hypercholesterolaemia; (iii) referred for assessment for familial hypercholesterolemia; or (iv) genetically diagnosed with familial hypercholesterolaemia.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD108,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD108,"Percentage of patients aged 65 years or over prescribed a Non-Steroidal Anti-Inflammatory Drug (NSAID) and not an oral anticoagulant in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an NSAID or (ii) prescribed a gastro-protective in addition to an NSAID.",Exclusion,ACNOPQSNSD,ACNOPQSNSD,n/a,n/a,n/a,ACNOPQSNSD
tbc,2023-24,NCD,NCD,NCD109,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD109,"Percentage of patients aged 18 years or over prescribed both an oral anticoagulant and an anti-platelet in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an anti-platelet or (ii) prescribed a gastro-protective in addition to an anti-platelet.",Exclusion,NOPQSACSAL,NOPQSACSAL,n/a,n/a,n/a,NOPQSACSAL
tbc,2023-24,NCD,NCD,NCD112,Cancer,NCD,0,FI,NCD112,"Percentage of lower gastrointestinal two week wait (fast track) cancer referrals accompanied by a faecal immunochemical test result, with the result recorded either in the twenty-one days leading up to the referral, or in the fourteen days after the referral.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD117,Cardiovascular Disease Prevention,NCD,0,FI,NCD117,"Percentage of men aged 50 years or over and women aged 55 years or over, without established Cardiovascular Disease and not on lipid lowering therapy, who have a QRISK score recorded on their GP record in the preceding five years and who have a recording of cholesterol levels, blood pressure and smoking status in the 12 months preceding recording of the most recent QRISK score",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD120,Tackling Health Inequalities,NCD,0,FI,NCD120,"Percentage of patients on the QOF Learning Disability register aged 14 or over, who received an annual Learning Disability Health Check and have a completed Health Action Plan, in addition to a recording of ethnicity.",PCA,HLTHAPDEC,HLTHAPDEC,n/a,n/a,n/a,HLTHAPDEC
tbc,2023-24,NCD,NCD,NCD121,Cardiovascular Disease Prevention,NCD,0,FI,NCD121,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease or diabetes and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins, or where a statin is declined or clinically unsuitable, another lipid-lowering therapy.",Exclusion,CVDDIAG,CVDDIAG,n/a,n/a,n/a,CVDDIAG
tbc,2023-24,NCD,NCD,NCD121,Cardiovascular Disease Prevention,NCD,0,FI,NCD121,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease or diabetes and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins, or where a statin is declined or clinically unsuitable, another lipid-lowering therapy.",PCA,STATLLTDEC,STATLLTDEC,n/a,n/a,n/a,STATLLTDEC
tbc,2023-24,NCD,NCD,NCDMI026,Vaccination & Immunisation,NCD,0,FI,NCDMI026,Percentage of patients on the Learning Disability register aged 18 years or over who received a seasonal influenza vaccination between 1 September and 31 March.,Exclusion,LD_DAT,LD_DAT,n/a,n/a,n/a,LD_DAT
tbc,2023-24,NCD,NCD,NCDMI060,Tackling Health Inequalities,NCD,0,FI,NCDMI060,Percentage of registered patients who were given the opportunity to state their ethnicity but chose not to.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI061,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI061,"Percentage of patients aged 25 to 84 years inclusive and with a last recorded CVD risk score (QRISK2 or 3) greater than or equal to 10 percent, who are currently treated with statins.",Exclusion,QRISKVAL10,QRISKVAL10,n/a,n/a,n/a,QRISKVAL10
tbc,2023-24,NCD,NCD,NCDMI064,Personalised Care,NCD,0,FI,NCDMI064,"Percentage of patients with a long-term condition, whose care was discussed as part of a shared decision-making conversation.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI074,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI074,Percentage of registered patients prescribed opioids.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI074,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI074,Percentage of registered patients prescribed opioids.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI102,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI102,"Percentage of patients aged 18 years or over with an observation indicating suspected atrial fibrillation recorded during the financial year (including presentations of breathlessness, palpitations, syncope or dizziness, or chest discomfort) who received a pulse check.",Exclusion,UNRESAFIB,UNRESAFIB,n/a,n/a,n/a,UNRESAFIB
tbc,2023-24,NCD,NCD,NCDMI109,Personalised Care,NCD,0,FI,NCDMI109,Number of consultations per patient currently being seen by a social prescribing service.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI117,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI117,"Percentage of patients aged 18 years or over with a history of peptic ulceration and prescribed an oral non-steroidal anti-inflammatory drug (NSAID), who were not prescribed a gastro-protective.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI118,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI118,"Percentage of patients aged 18 years or over with a history of peptic ulceration and prescribed an anti-platelet, who were not prescribed a gastro-protective",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI120,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI120,"Percentage of patients aged 18 years or over prescribed an oral anticoagulant and an anti-platelet, who were not prescribed a gastro-protective.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI122,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI122,Percentage of patients aged 18 years or over with heart failure who were prescribed an oral non-steroidal anti-inflammatory drug (NSAID).,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI133,Tackling Health Inequalities,NCD,0,FI,NCDMI133,Percentage of patients aged 45 or over and recorded as being from an ethnic minority who have a record of blood pressure in the preceding 5 years,Exclusion,PAT_AGEU45,PAT_AGEU45,n/a,n/a,n/a,PAT_AGEU45
tbc,2023-24,NCD,NCD,NCDMI143,Workforce,NCD,0,FI,NCDMI143,Percentage of registered patients who had at least one encounter with a Physician Associate.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI145,Workforce,NCD,0,FI,NCDMI145,Percentage of registered patients who had at least one encounter with a Dietitian.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI156,Workforce,NCD,0,FI,NCDMI156,Number of encounters with a Care Coordinator per registered patient.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI158,Workforce,NCD,0,FI,NCDMI158,"Number of encounters with a Trainee Nursing Associate, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI166,Access,NCD,0,FI,NCDMI166,Number of declined referrals to the Community Pharmacy Consultation Service per registered patient,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI170,Enhanced Health in Care Homes,NCD,0,FI,NCDMI170,Percentage of permanent care home residents aged 18 years or over who received a psychosocial assessment,PCA,CARHOMDEC1,CARHOMDEC1,n/a,n/a,n/a,CARHOMDEC1
tbc,2023-24,NCD,NCD,NCDMI172,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI172,Percentage of patients aged 18 years or over prescribed methotrexate for at least 3 months without a full blood count in the previous 3 months.,Exclusion,NOMETH3M6M,NOMETH3M6M,n/a,n/a,n/a,NOMETH3M6M
tbc,2023-24,NCD,NCD,NCDMI176,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI176,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins.",PCA,TXSTAT_DAT,TXSTAT_DAT,n/a,n/a,n/a,TXSTAT_DAT
tbc,2023-24,NCD,NCD,NCDMI182,Tackling Health Inequalities,NCD,0,FI,NCDMI182,"Percentage of patients on the QOF Learning Disability register aged 14 years or over, who received an annual Learning Disability Health Check and a completed Health Action Plan.",PCA,HLTHCHKDEC,HLTHCHKDEC,n/a,n/a,n/a,HLTHCHKDEC
tbc,2023-24,NCD,NCD,NCDMI189,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI189,"Percentage of permanent care home residents aged 18 years or over, who received a Structured Medication Review.",PCA,PALCARDAT2,PALCARDAT2,n/a,n/a,n/a,PALCARDAT2
tbc,2023-24,NCD,NCD,NCDMI199,Vaccination & Immunisation,NCD,0,FI,NCDMI199,"Percentage of patients aged 65 years or over, who received a seasonal influenza vaccination between 1 September and 31 March.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD003,Vaccination & Immunisation,NCD,0,FI,NCD003,Percentage of at-risk patients aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,XFLU_DAT,XFLU_DAT,n/a,n/a,n/a,XFLU_DAT
tbc,2023-24,NCD,NCD,NCD011,Cardiovascular Disease Prevention,NCD,0,FI,NCD011,"Percentage of patients aged 18 years or over, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90mmHg (with the exception of patients whose first blood pressure reading >= 140/90mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Exclusion,PRELAT6M,PRELAT6M,n/a,n/a,n/a,PRELAT6M
tbc,2023-24,NCD,NCD,NCD107,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD107,"Percentage of patients aged 18 years or over prescribed both a Non-Steroidal Anti-Inflammatory Drug (NSAID) and an oral anticoagulant in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an NSAID or (ii) prescribed a gastro-protective in addition to an NSAID.",Exclusion,NOPQSNSDAC,NOPQSNSDAC,n/a,n/a,n/a,NOPQSNSDAC
tbc,2023-24,NCD,NCD,NCD107,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD107,"Percentage of patients aged 18 years or over prescribed both a Non-Steroidal Anti-Inflammatory Drug (NSAID) and an oral anticoagulant in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an NSAID or (ii) prescribed a gastro-protective in addition to an NSAID.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD108,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD108,"Percentage of patients aged 65 years or over prescribed a Non-Steroidal Anti-Inflammatory Drug (NSAID) and not an oral anticoagulant in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an NSAID or (ii) prescribed a gastro-protective in addition to an NSAID.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD109,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD109,"Percentage of patients aged 18 years or over prescribed both an oral anticoagulant and an anti-platelet in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an anti-platelet or (ii) prescribed a gastro-protective in addition to an anti-platelet.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD113,Access,NCD,0,FI,NCD113,Number of referrals to the Community Pharmacist Consultation Service per registered patient,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD117,Cardiovascular Disease Prevention,NCD,0,FI,NCD117,"Percentage of men aged 50 years or over and women aged 55 years or over, without established Cardiovascular Disease and not on lipid lowering therapy, who have a QRISK score recorded on their GP record in the preceding five years and who have a recording of cholesterol levels, blood pressure and smoking status in the 12 months preceding recording of the most recent QRISK score",Exclusion,AGEUM50F55,AGEUM50F55,n/a,n/a,n/a,AGEUM50F55
tbc,2023-24,NCD,NCD,NCD117,Cardiovascular Disease Prevention,NCD,0,FI,NCD117,"Percentage of men aged 50 years or over and women aged 55 years or over, without established Cardiovascular Disease and not on lipid lowering therapy, who have a QRISK score recorded on their GP record in the preceding five years and who have a recording of cholesterol levels, blood pressure and smoking status in the 12 months preceding recording of the most recent QRISK score",Exclusion,LIPIDTHER,LIPIDTHER,n/a,n/a,n/a,LIPIDTHER
tbc,2023-24,NCD,NCD,NCD120,Tackling Health Inequalities,NCD,0,FI,NCD120,"Percentage of patients on the QOF Learning Disability register aged 14 or over, who received an annual Learning Disability Health Check and have a completed Health Action Plan, in addition to a recording of ethnicity.",Exclusion,PAT_AGEU14,PAT_AGEU14,n/a,n/a,n/a,PAT_AGEU14
tbc,2023-24,NCD,NCD,NCDMI027,Vaccination & Immunisation,NCD,0,FI,NCDMI027,"Percentage of patients on the QOF Mental Health register for schizophrenia, bipolar affective disorder and other psychoses and either aged 65 years or over, or aged between 18 and 64 years inclusive and in a clinical at-risk group, who received a seasonal influenza vaccination between 1 September and 31 March.",PCA,XFLU_DAT,XFLU_DAT,n/a,n/a,n/a,XFLU_DAT
tbc,2023-24,NCD,NCD,NCDMI101,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI101,"Percentage of patients aged 65 years or over and who received a blood pressure check, who received a pulse check",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI103,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI103,Percentage of patients aged 65 years or over and with an irregular pulse who either received an electrocardiogram or were referred for an electrocardiogram.,Exclusion,UNRESAFIB,UNRESAFIB,n/a,n/a,n/a,UNRESAFIB
tbc,2023-24,NCD,NCD,NCDMI105,Personalised Care,NCD,0,FI,NCDMI105,Number of Social Prescribing Link Worker consultations per patient currently being seen by a social prescribing service.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI107,Personalised Care,NCD,0,FI,NCDMI107,Percentage of patients currently being seen by a social prescribing service who received at least one consultation with a Social Prescribing Link Worker.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI107,Personalised Care,NCD,0,FI,NCDMI107,Percentage of patients currently being seen by a social prescribing service who received at least one consultation with a Social Prescribing Link Worker.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI108,Personalised Care,NCD,0,FI,NCDMI108,Number of General Practitioner consultations per registered patient.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI114,Enhanced Health in Care Homes,NCD,0,FI,NCDMI114,Mean number of Multidisciplinary Team meetings per care home resident aged 18 years or over.,Exclusion,NURSHOME,NURSHOME,n/a,n/a,n/a,NURSHOME
tbc,2023-24,NCD,NCD,NCDMI116,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI116,"Percentage of patients aged 65 years or over prescribed an oral non-steroidal anti-inflammatory drug (NSAID), who were not prescribed a gastro-protective",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI121,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI121,"Percentage of patients aged 18 years or over prescribed aspirin and another anti-platelet, who were not prescribed a gastro-protective.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI121,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI121,"Percentage of patients aged 18 years or over prescribed aspirin and another anti-platelet, who were not prescribed a gastro-protective.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI124,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI124,Percentage of patients aged 18 years or over with an unresolved asthma diagnosis who were prescribed a non-selective beta-blocker.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI129,Tackling Health Inequalities,NCD,0,FI,NCDMI129,Percentage of at-risk patients recorded as being from an ethnic minority and aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI130,Tackling Health Inequalities,NCD,0,FI,NCDMI130,Percentage of patients aged 16 years or over who have received a second dose of a Covid 19 vaccination,Exclusion,PAT_AGEU16,PAT_AGEU16,n/a,n/a,n/a,PAT_AGEU16
tbc,2023-24,NCD,NCD,NCDMI131,Tackling Health Inequalities,NCD,0,FI,NCDMI131,Percentage of patients aged 16 years or over and recorded as being from an ethnic minority who have received a second dose of a Covid 19 vaccination,PCA,C19CON_DAT,C19CON_DAT,n/a,n/a,n/a,C19CON_DAT
tbc,2023-24,NCD,NCD,NCDMI131,Tackling Health Inequalities,NCD,0,FI,NCDMI131,Percentage of patients aged 16 years or over and recorded as being from an ethnic minority who have received a second dose of a Covid 19 vaccination,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Exclusion,HYPLATUNR,HYPLATUNR,n/a,n/a,n/a,HYPLATUNR
tbc,2023-24,NCD,NCD,NCDMI136,Tackling Health Inequalities,NCD,0,FI,NCDMI136,Number of registered patients with a Type 1 Opt Out,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI139,Workforce,NCD,0,FI,NCDMI139,Percentage of registered patients who had at least one encounter with a Clinical Pharmacist.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI140,Workforce,NCD,0,FI,NCDMI140,"Number of encounters with a First Contact Physiotherapist, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI148,Workforce,NCD,0,FI,NCDMI148,"Number of encounters with a Pharmacy Technician, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI153,Workforce,NCD,0,FI,NCDMI153,Percentage of registered patients who had at least one encounter with a Social Prescribing Link Worker.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI154,Workforce,NCD,0,FI,NCDMI154,"Number of encounters with a Health and Wellbeing Coach, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI159,Workforce,NCD,0,FI,NCDMI159,Percentage of registered patients who had at least one encounter with a Trainee Nursing Associate.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI177,Respiratory Care,NCD,0,FI,NCDMI177,"Percentage of patients on the QOF Asthma Register who received three or more inhaled corticosteroid (ICS, inclusive of ICS/LABA) prescriptions over the previous 12 months.",PCA,MILDINTAST,MILDINTAST,n/a,n/a,n/a,MILDINTAST
tbc,2023-24,NCD,NCD,NCDMI180,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI180,Percentage of patients at risk of harm due to medication errors who received a Structured Medication Review.,PCA,MEDRVWDEC,MEDRVWDEC,n/a,n/a,n/a,MEDRVWDEC
tbc,2023-24,NCD,NCD,NCDMI180,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI180,Percentage of patients at risk of harm due to medication errors who received a Structured Medication Review.,Exclusion,NOMEDERR1,NOMEDERR1,n/a,n/a,n/a,NOMEDERR1
tbc,2023-24,NCD,NCD,NCDMI189,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI189,"Percentage of permanent care home residents aged 18 years or over, who received a Structured Medication Review.",PCA,CARHOMDEC1,CARHOMDEC1,n/a,n/a,n/a,CARHOMDEC1
tbc,2023-24,NCD,NCD,NCDMI189,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI189,"Percentage of permanent care home residents aged 18 years or over, who received a Structured Medication Review.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI189,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI189,"Percentage of permanent care home residents aged 18 years or over, who received a Structured Medication Review.",PCA,STRMEDRVDC,STRMEDRVDC,n/a,n/a,n/a,STRMEDRVDC
tbc,2023-24,NCD,NCD,NCD003,Vaccination & Immunisation,NCD,0,FI,NCD003,Percentage of at-risk patients aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUDEC_DAT,FLUDEC_DAT,n/a,n/a,n/a,FLUDEC_DAT
tbc,2023-24,NCD,NCD,NCD003,Vaccination & Immunisation,NCD,0,FI,NCD003,Percentage of at-risk patients aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD018,Enhanced Health in Care Homes,NCD,0,FI,NCD018,"Percentage of care home residents aged 18 years or over, who had a Personalised Care and Support Plan agreed or reviewed.",Exclusion,HOMETMP_18,HOMETMP_18,n/a,n/a,n/a,HOMETMP_18
tbc,2023-24,NCD,NCD,NCD026,Access,NCD,0,FI,NCD026,Percentage of appointments where time from booking to appointment was two weeks or less,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD026,Access,NCD,0,FI,NCD026,Percentage of appointments where time from booking to appointment was two weeks or less,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD108,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD108,"Percentage of patients aged 65 years or over prescribed a Non-Steroidal Anti-Inflammatory Drug (NSAID) and not an oral anticoagulant in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an NSAID or (ii) prescribed a gastro-protective in addition to an NSAID.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD108,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD108,"Percentage of patients aged 65 years or over prescribed a Non-Steroidal Anti-Inflammatory Drug (NSAID) and not an oral anticoagulant in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an NSAID or (ii) prescribed a gastro-protective in addition to an NSAID.",Exclusion,PAT_AGEU65,PAT_AGEU65,n/a,n/a,n/a,PAT_AGEU65
tbc,2023-24,NCD,NCD,NCD111,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD111,"Percentage of patients prescribed a direct-acting oral anticoagulant, who received a renal function test and a recording of their weight and Creatinine Clearance Rate, along with a change or confirmation of their medication dose.",PCA,DOAC3MDAT1,DOAC3MDAT1,n/a,n/a,n/a,DOAC3MDAT1
tbc,2023-24,NCD,NCD,NCD111,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD111,"Percentage of patients prescribed a direct-acting oral anticoagulant, who received a renal function test and a recording of their weight and Creatinine Clearance Rate, along with a change or confirmation of their medication dose.",PCA,DOAC9MDAT1,DOAC9MDAT1,n/a,n/a,n/a,DOAC9MDAT1
tbc,2023-24,NCD,NCD,NCD117,Cardiovascular Disease Prevention,NCD,0,FI,NCD117,"Percentage of men aged 50 years or over and women aged 55 years or over, without established Cardiovascular Disease and not on lipid lowering therapy, who have a QRISK score recorded on their GP record in the preceding five years and who have a recording of cholesterol levels, blood pressure and smoking status in the 12 months preceding recording of the most recent QRISK score",Exclusion,DIBFRISTAT,DIBFRISTAT,n/a,n/a,n/a,DIBFRISTAT
tbc,2023-24,NCD,NCD,NCD120,Tackling Health Inequalities,NCD,0,FI,NCD120,"Percentage of patients on the QOF Learning Disability register aged 14 or over, who received an annual Learning Disability Health Check and have a completed Health Action Plan, in addition to a recording of ethnicity.",PCA,HLTHCHKDEC,HLTHCHKDEC,n/a,n/a,n/a,HLTHCHKDEC
tbc,2023-24,NCD,NCD,NCD121,Cardiovascular Disease Prevention,NCD,0,FI,NCD121,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease or diabetes and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins, or where a statin is declined or clinically unsuitable, another lipid-lowering therapy.",PCA,CHOLMX_DAT,CHOLMX_DAT,n/a,n/a,n/a,CHOLMX_DAT
tbc,2023-24,NCD,NCD,NCDMI002,Personalised Care,NCD,0,FI,NCDMI002,Percentage of registered patients who had a Personalised Care and Support Plan reviewed.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI024,Early Cancer Diagnosis,NCD,0,FI,NCDMI024,Percentage of patients placed on an urgent referral pathway for suspected cancer where safety netting was recorded.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI025,Vaccination & Immunisation,NCD,0,FI,NCDMI025,Percentage of patients in long stay residential or homes who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,XFLU_DAT,XFLU_DAT,n/a,n/a,n/a,XFLU_DAT
tbc,2023-24,NCD,NCD,NCDMI026,Vaccination & Immunisation,NCD,0,FI,NCDMI026,Percentage of patients on the Learning Disability register aged 18 years or over who received a seasonal influenza vaccination between 1 September and 31 March.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI068,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI068,Mean number of structured medication reviews undertaken per registered patient.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI103,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI103,Percentage of patients aged 65 years or over and with an irregular pulse who either received an electrocardiogram or were referred for an electrocardiogram.,Exclusion,NOIRREGPLS,NOIRREGPLS,n/a,n/a,n/a,NOIRREGPLS
tbc,2023-24,NCD,NCD,NCDMI114,Enhanced Health in Care Homes,NCD,0,FI,NCDMI114,Mean number of Multidisciplinary Team meetings per care home resident aged 18 years or over.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI116,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI116,"Percentage of patients aged 65 years or over prescribed an oral non-steroidal anti-inflammatory drug (NSAID), who were not prescribed a gastro-protective",Exclusion,PAT_AGEU65,PAT_AGEU65,n/a,n/a,n/a,PAT_AGEU65
tbc,2023-24,NCD,NCD,NCDMI117,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI117,"Percentage of patients aged 18 years or over with a history of peptic ulceration and prescribed an oral non-steroidal anti-inflammatory drug (NSAID), who were not prescribed a gastro-protective.",Exclusion,NONSAID3M,NONSAID3M,n/a,n/a,n/a,NONSAID3M
tbc,2023-24,NCD,NCD,NCDMI117,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI117,"Percentage of patients aged 18 years or over with a history of peptic ulceration and prescribed an oral non-steroidal anti-inflammatory drug (NSAID), who were not prescribed a gastro-protective.",Exclusion,PEPULCB3M,PEPULCB3M,n/a,n/a,n/a,PEPULCB3M
tbc,2023-24,NCD,NCD,NCDMI118,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI118,"Percentage of patients aged 18 years or over with a history of peptic ulceration and prescribed an anti-platelet, who were not prescribed a gastro-protective",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI121,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI121,"Percentage of patients aged 18 years or over prescribed aspirin and another anti-platelet, who were not prescribed a gastro-protective.",Exclusion,NOASPLAT3M,NOASPLAT3M,n/a,n/a,n/a,NOASPLAT3M
tbc,2023-24,NCD,NCD,NCDMI122,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI122,Percentage of patients aged 18 years or over with heart failure who were prescribed an oral non-steroidal anti-inflammatory drug (NSAID).,Exclusion,HFB3M_DAT,HFB3M_DAT,n/a,n/a,n/a,HFB3M_DAT
tbc,2023-24,NCD,NCD,NCDMI129,Tackling Health Inequalities,NCD,0,FI,NCDMI129,Percentage of at-risk patients recorded as being from an ethnic minority and aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Exclusion,PRELAT6M,PRELAT6M,n/a,n/a,n/a,PRELAT6M
tbc,2023-24,NCD,NCD,NCDMI134,Tackling Health Inequalities,NCD,0,FI,NCDMI134,"Percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who received all six elements of the Physical Health Check for people with Severe Mental Illness.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI135,Tackling Health Inequalities,NCD,0,FI,NCDMI135,"Percentage of patients with schizophrenia, bipolar affective disorder and other psychoses and recorded as being from an ethnic minority who received all six elements of the Physical Health Check for people with Severe Mental Illness",Exclusion,MH_MHREM,MH_MHREM,n/a,n/a,n/a,MH_MHREM
tbc,2023-24,NCD,NCD,NCDMI135,Tackling Health Inequalities,NCD,0,FI,NCDMI135,"Percentage of patients with schizophrenia, bipolar affective disorder and other psychoses and recorded as being from an ethnic minority who received all six elements of the Physical Health Check for people with Severe Mental Illness",Exclusion,PAT_ETHWNS,PAT_ETHWNS,n/a,n/a,n/a,PAT_ETHWNS
tbc,2023-24,NCD,NCD,NCDMI152,Workforce,NCD,0,FI,NCDMI152,"Number of encounters with a Social Prescribing Link Worker, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI157,Workforce,NCD,0,FI,NCDMI157,Percentage of registered patients who had at least one encounter with a Care Coordinator.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI161,Workforce,NCD,0,FI,NCDMI161,Percentage of registered patients who had at least one encounter with a Nursing Associate.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI162,Workforce,NCD,0,FI,NCDMI162,"Number of encounters with a Paramedic, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI163,Workforce,NCD,0,FI,NCDMI163,Percentage of registered patients who had at least one encounter with a Paramedic.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI164,Workforce,NCD,0,FI,NCDMI164,"Number of encounters with a Mental Health Practitioner, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI167,Enhanced Health in Care Homes,NCD,0,FI,NCDMI167,Percentage of permanent care home residents aged 18 years or over who received a falls risk assessment.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI171,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI171,Percentage of patients aged 75 years or over on a long-term prescription of an angiotensin converting enzyme (ACE) inhibitor or a loop diuretic who have not had their renal function and electrolytes recorded in the previous 15 months.,Exclusion,PAT_AGEU75,PAT_AGEU75,n/a,n/a,n/a,PAT_AGEU75
tbc,2023-24,NCD,NCD,NCDMI177,Respiratory Care,NCD,0,FI,NCDMI177,"Percentage of patients on the QOF Asthma Register who received three or more inhaled corticosteroid (ICS, inclusive of ICS/LABA) prescriptions over the previous 12 months.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI178,Respiratory Care,NCD,0,FI,NCDMI178,Percentage of patients on the QOF asthma register who received 6 or more Short Acting Beta-2 Agonist (SABA) inhaler prescriptions over the previous 12 months.,Exclusion,EUNRESCOAS,EUNRESCOAS,n/a,n/a,n/a,EUNRESCOAS
tbc,2023-24,NCD,NCD,NCDMI178,Respiratory Care,NCD,0,FI,NCDMI178,Percentage of patients on the QOF asthma register who received 6 or more Short Acting Beta-2 Agonist (SABA) inhaler prescriptions over the previous 12 months.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI199,Vaccination & Immunisation,NCD,0,FI,NCDMI199,"Percentage of patients aged 65 years or over, who received a seasonal influenza vaccination between 1 September and 31 March.",Exclusion,PAT_AGEU65,PAT_AGEU65,n/a,n/a,n/a,PAT_AGEU65
tbc,2023-24,NCD,NCD,NCD011,Cardiovascular Disease Prevention,NCD,0,FI,NCD011,"Percentage of patients aged 18 years or over, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90mmHg (with the exception of patients whose first blood pressure reading >= 140/90mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI023,Early Cancer Diagnosis,NCD,0,FI,NCDMI023,Percentage of patients who were placed on an urgent referral pathway for suspected cancer.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI026,Vaccination & Immunisation,NCD,0,FI,NCDMI026,Percentage of patients on the Learning Disability register aged 18 years or over who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUDEC_DAT,FLUDEC_DAT,n/a,n/a,n/a,FLUDEC_DAT
tbc,2023-24,NCD,NCD,NCDMI026,Vaccination & Immunisation,NCD,0,FI,NCDMI026,Percentage of patients on the Learning Disability register aged 18 years or over who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUEXPCON,FLUEXPCON,n/a,n/a,n/a,FLUEXPCON
tbc,2023-24,NCD,NCD,NCDMI026,Vaccination & Immunisation,NCD,0,FI,NCDMI026,Percentage of patients on the Learning Disability register aged 18 years or over who received a seasonal influenza vaccination between 1 September and 31 March.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI026,Vaccination & Immunisation,NCD,0,FI,NCDMI026,Percentage of patients on the Learning Disability register aged 18 years or over who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,XFLU_DAT,XFLU_DAT,n/a,n/a,n/a,XFLU_DAT
tbc,2023-24,NCD,NCD,NCDMI060,Tackling Health Inequalities,NCD,0,FI,NCDMI060,Percentage of registered patients who were given the opportunity to state their ethnicity but chose not to.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI089,Environmental Sustainability,NCD,0,FI,NCDMI089,Percentage of salbutamol inhaler prescriptions that are lower carbon.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI103,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI103,Percentage of patients aged 65 years or over and with an irregular pulse who either received an electrocardiogram or were referred for an electrocardiogram.,Exclusion,PAT_AGEU65,PAT_AGEU65,n/a,n/a,n/a,PAT_AGEU65
tbc,2023-24,NCD,NCD,NCDMI106,Personalised Care,NCD,0,FI,NCDMI106,Number of General Practitioner consultations per patient currently being seen by a social prescribing service.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI122,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI122,Percentage of patients aged 18 years or over with heart failure who were prescribed an oral non-steroidal anti-inflammatory drug (NSAID).,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI129,Tackling Health Inequalities,NCD,0,FI,NCDMI129,Percentage of at-risk patients recorded as being from an ethnic minority and aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March,Exclusion,PAT_ETHWNS,PAT_ETHWNS,n/a,n/a,n/a,PAT_ETHWNS
tbc,2023-24,NCD,NCD,NCDMI130,Tackling Health Inequalities,NCD,0,FI,NCDMI130,Percentage of patients aged 16 years or over who have received a second dose of a Covid 19 vaccination,PCA,C19CON_DAT,C19CON_DAT,n/a,n/a,n/a,C19CON_DAT
tbc,2023-24,NCD,NCD,NCDMI130,Tackling Health Inequalities,NCD,0,FI,NCDMI130,Percentage of patients aged 16 years or over who have received a second dose of a Covid 19 vaccination,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI141,Workforce,NCD,0,FI,NCDMI141,Percentage of registered patients who had at least one encounter with a First Contact Physiotherapist.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI146,Workforce,NCD,0,FI,NCDMI146,"Number of encounters with a Podiatrist, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI176,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI176,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins.",Exclusion,CVDPAL_DAT,CVDPAL_DAT,n/a,n/a,n/a,CVDPAL_DAT
tbc,2023-24,NCD,NCD,NCDMI199,Vaccination & Immunisation,NCD,0,FI,NCDMI199,"Percentage of patients aged 65 years or over, who received a seasonal influenza vaccination between 1 September and 31 March.",PCA,FLUINVITE1,FLUINVITE1,n/a,n/a,n/a,FLUINVITE1
tbc,2023-24,NCD,NCD,NCD004,Vaccination & Immunisation,NCD,0,FI,NCD004,Percentage of patients aged two or three years on 31 August of the relevant financial year who received a seasonal influenza vaccination between 1 September and 31 March.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD011,Cardiovascular Disease Prevention,NCD,0,FI,NCD011,"Percentage of patients aged 18 years or over, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90mmHg (with the exception of patients whose first blood pressure reading >= 140/90mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",PCA,ABPDEC12M,ABPDEC12M,n/a,n/a,n/a,ABPDEC12M
tbc,2023-24,NCD,NCD,NCD102,Cardiovascular Disease Prevention,NCD,0,FI,NCD102,Percentage of patients aged 29 and under with a total cholesterol greater than 7.5mmol/L OR aged 30 and over with a total cholesterol greater than 9.0mmol/L who have been either: (i) diagnosed with secondary hyperlipidaemia; (ii) clinically assessed for familial hypercholesterolaemia; (iii) referred for assessment for familial hypercholesterolemia; or (iv) genetically diagnosed with familial hypercholesterolaemia.,PCA,FAMHYPRDEC,FAMHYPRDEC,n/a,n/a,n/a,FAMHYPRDEC
tbc,2023-24,NCD,NCD,NCD112,Cancer,NCD,0,FI,NCD112,"Percentage of lower gastrointestinal two week wait (fast track) cancer referrals accompanied by a faecal immunochemical test result, with the result recorded either in the twenty-one days leading up to the referral, or in the fourteen days after the referral.",PCA,FITNIDAT,FITNIDAT,n/a,n/a,n/a,FITNIDAT
tbc,2023-24,NCD,NCD,NCD117,Cardiovascular Disease Prevention,NCD,0,FI,NCD117,"Percentage of men aged 50 years or over and women aged 55 years or over, without established Cardiovascular Disease and not on lipid lowering therapy, who have a QRISK score recorded on their GP record in the preceding five years and who have a recording of cholesterol levels, blood pressure and smoking status in the 12 months preceding recording of the most recent QRISK score",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD120,Tackling Health Inequalities,NCD,0,FI,NCD120,"Percentage of patients on the QOF Learning Disability register aged 14 or over, who received an annual Learning Disability Health Check and have a completed Health Action Plan, in addition to a recording of ethnicity.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI003,Personalised Care,NCD,0,FI,NCDMI003,Percentage of registered patients whose care has been discussed as part of a shared decision-making process.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI025,Vaccination & Immunisation,NCD,0,FI,NCDMI025,Percentage of patients in long stay residential or homes who received a seasonal influenza vaccination between 1 September and 31 March.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI102,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI102,"Percentage of patients aged 18 years or over with an observation indicating suspected atrial fibrillation recorded during the financial year (including presentations of breathlessness, palpitations, syncope or dizziness, or chest discomfort) who received a pulse check.",Exclusion,BTHPALDIZC,BTHPALDIZC,n/a,n/a,n/a,BTHPALDIZC
tbc,2023-24,NCD,NCD,NCDMI120,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI120,"Percentage of patients aged 18 years or over prescribed an oral anticoagulant and an anti-platelet, who were not prescribed a gastro-protective.",Exclusion,NOCOAGPLAT,NOCOAGPLAT,n/a,n/a,n/a,NOCOAGPLAT
tbc,2023-24,NCD,NCD,NCDMI120,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI120,"Percentage of patients aged 18 years or over prescribed an oral anticoagulant and an anti-platelet, who were not prescribed a gastro-protective.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI134,Tackling Health Inequalities,NCD,0,FI,NCDMI134,"Percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who received all six elements of the Physical Health Check for people with Severe Mental Illness.",Exclusion,MH_MHREM,MH_MHREM,n/a,n/a,n/a,MH_MHREM
tbc,2023-24,NCD,NCD,NCDMI151,Workforce,NCD,0,FI,NCDMI151,Percentage of registered patients who had at least one encounter with an Occupational Therapist.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI171,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI171,Percentage of patients aged 75 years or over on a long-term prescription of an angiotensin converting enzyme (ACE) inhibitor or a loop diuretic who have not had their renal function and electrolytes recorded in the previous 15 months.,Exclusion,NOACELOOP,NOACELOOP,n/a,n/a,n/a,NOACELOOP
tbc,2023-24,NCD,NCD,NCDMI176,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI176,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins.",Exclusion,P_AGE25_84,P_AGE25_84,n/a,n/a,n/a,P_AGE25_84
tbc,2023-24,NCD,NCD,NCDMI181,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI181,Percentage of patients living with severe frailty who received a Structured Medication Review.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI182,Tackling Health Inequalities,NCD,0,FI,NCDMI182,"Percentage of patients on the QOF Learning Disability register aged 14 years or over, who received an annual Learning Disability Health Check and a completed Health Action Plan.",Exclusion,PAT_AGEU14,PAT_AGEU14,n/a,n/a,n/a,PAT_AGEU14
tbc,2023-24,NCD,NCD,NCD011,Cardiovascular Disease Prevention,NCD,0,FI,NCD011,"Percentage of patients aged 18 years or over, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90mmHg (with the exception of patients whose first blood pressure reading >= 140/90mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCD018,Enhanced Health in Care Homes,NCD,0,FI,NCD018,"Percentage of care home residents aged 18 years or over, who had a Personalised Care and Support Plan agreed or reviewed.",PCA,PCSPDEC,PCSPDEC,n/a,n/a,n/a,PCSPDEC
tbc,2023-24,NCD,NCD,NCD121,Cardiovascular Disease Prevention,NCD,0,FI,NCD121,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease or diabetes and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins, or where a statin is declined or clinically unsuitable, another lipid-lowering therapy.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD121,Cardiovascular Disease Prevention,NCD,0,FI,NCD121,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease or diabetes and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins, or where a statin is declined or clinically unsuitable, another lipid-lowering therapy.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD123,Cancer,NCD,0,FI,NCD123,"Percentage of lower gastrointestinal two week wait (fast track) cancer referrals accompanied by a faecal immunochemical test result, with the result recorded in the twenty-one days leading up to the referral.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI026,Vaccination & Immunisation,NCD,0,FI,NCDMI026,Percentage of patients on the Learning Disability register aged 18 years or over who received a seasonal influenza vaccination between 1 September and 31 March.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI027,Vaccination & Immunisation,NCD,0,FI,NCDMI027,"Percentage of patients on the QOF Mental Health register for schizophrenia, bipolar affective disorder and other psychoses and either aged 65 years or over, or aged between 18 and 64 years inclusive and in a clinical at-risk group, who received a seasonal influenza vaccination between 1 September and 31 March.",Exclusion,NATRISKU18,NATRISKU18,n/a,n/a,n/a,NATRISKU18
tbc,2023-24,NCD,NCD,NCDMI028,Tackling Health Inequalities,NCD,0,FI,NCDMI028,Percentage of patients aged 14 years or over and on the QOF Learning Disability Register who received a Learning Disability Annual Health Check.,Exclusion,PAT_AGEU14,PAT_AGEU14,n/a,n/a,n/a,PAT_AGEU14
tbc,2023-24,NCD,NCD,NCDMI061,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI061,"Percentage of patients aged 25 to 84 years inclusive and with a last recorded CVD risk score (QRISK2 or 3) greater than or equal to 10 percent, who are currently treated with statins.",PCA,STATDECAW,STATDECAW,n/a,n/a,n/a,STATDECAW
tbc,2023-24,NCD,NCD,NCDMI103,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI103,Percentage of patients aged 65 years or over and with an irregular pulse who either received an electrocardiogram or were referred for an electrocardiogram.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI110,Personalised Care,NCD,0,FI,NCDMI110,Number of consultations per registered patient.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI113,Enhanced Health in Care Homes,NCD,0,FI,NCDMI113,Percentage of permanent care home residents aged 18 years or over with a preferred place of death recorded.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI146,Workforce,NCD,0,FI,NCDMI146,"Number of encounters with a Podiatrist, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI154,Workforce,NCD,0,FI,NCDMI154,"Number of encounters with a Health and Wellbeing Coach, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI156,Workforce,NCD,0,FI,NCDMI156,Number of encounters with a Care Coordinator per registered patient.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI171,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI171,Percentage of patients aged 75 years or over on a long-term prescription of an angiotensin converting enzyme (ACE) inhibitor or a loop diuretic who have not had their renal function and electrolytes recorded in the previous 15 months.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI172,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI172,Percentage of patients aged 18 years or over prescribed methotrexate for at least 3 months without a full blood count in the previous 3 months.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI180,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI180,Percentage of patients at risk of harm due to medication errors who received a Structured Medication Review.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI188,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI188,Percentage of patients using potentially addictive medicines who received a Structured Medication Review.,PCA,PALCARDAT2,PALCARDAT2,n/a,n/a,n/a,PALCARDAT2
tbc,2023-24,NCD,NCD,NCD011,Cardiovascular Disease Prevention,NCD,0,FI,NCD011,"Percentage of patients aged 18 years or over, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90mmHg (with the exception of patients whose first blood pressure reading >= 140/90mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",PCA,PALCARDAT2,PALCARDAT2,n/a,n/a,n/a,PALCARDAT2
tbc,2023-24,NCD,NCD,NCD110,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD110,"Percentage of patients aged 18 years or over prescribed aspirin and another anti-platelet in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed aspirin and/or no longer prescribed an anti-platelet or (ii) prescribed a gastro-protective in addition to both aspirin and another anti-platelet.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI061,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI061,"Percentage of patients aged 25 to 84 years inclusive and with a last recorded CVD risk score (QRISK2 or 3) greater than or equal to 10 percent, who are currently treated with statins.",PCA,TXSTAT_DAT,TXSTAT_DAT,n/a,n/a,n/a,TXSTAT_DAT
tbc,2023-24,NCD,NCD,NCDMI064,Personalised Care,NCD,0,FI,NCDMI064,"Percentage of patients with a long-term condition, whose care was discussed as part of a shared decision-making conversation.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI102,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI102,"Percentage of patients aged 18 years or over with an observation indicating suspected atrial fibrillation recorded during the financial year (including presentations of breathlessness, palpitations, syncope or dizziness, or chest discomfort) who received a pulse check.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI105,Personalised Care,NCD,0,FI,NCDMI105,Number of Social Prescribing Link Worker consultations per patient currently being seen by a social prescribing service.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI119,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI119,"Percentage of patients aged 18 years or over prescribed an oral anticoagulant, who were prescribed an oral NSAID.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI122,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI122,Percentage of patients aged 18 years or over with heart failure who were prescribed an oral non-steroidal anti-inflammatory drug (NSAID).,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Exclusion,PAT_ETHWNS,PAT_ETHWNS,n/a,n/a,n/a,PAT_ETHWNS
tbc,2023-24,NCD,NCD,NCDMI142,Workforce,NCD,0,FI,NCDMI142,"Number of encounters with a Physician Associate, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI143,Workforce,NCD,0,FI,NCDMI143,Percentage of registered patients who had at least one encounter with a Physician Associate.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI150,Workforce,NCD,0,FI,NCDMI150,"Number of encounters with an Occupational Therapist, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI155,Workforce,NCD,0,FI,NCDMI155,Percentage of registered patients who had at least one encounter with a Health and Wellbeing Coach.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI177,Respiratory Care,NCD,0,FI,NCDMI177,"Percentage of patients on the QOF Asthma Register who received three or more inhaled corticosteroid (ICS, inclusive of ICS/LABA) prescriptions over the previous 12 months.",PCA,AST_DAT9M,AST_DAT9M,n/a,n/a,n/a,AST_DAT9M
tbc,2023-24,NCD,NCD,NCDMI180,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI180,Percentage of patients at risk of harm due to medication errors who received a Structured Medication Review.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI199,Vaccination & Immunisation,NCD,0,FI,NCDMI199,"Percentage of patients aged 65 years or over, who received a seasonal influenza vaccination between 1 September and 31 March.",PCA,XFLU_DAT,XFLU_DAT,n/a,n/a,n/a,XFLU_DAT
tbc,2023-24,NCD,NCD,NCD112,Cancer,NCD,0,FI,NCD112,"Percentage of lower gastrointestinal two week wait (fast track) cancer referrals accompanied by a faecal immunochemical test result, with the result recorded either in the twenty-one days leading up to the referral, or in the fourteen days after the referral.",Exclusion,GICANREF,GICANREF,n/a,n/a,n/a,GICANREF
tbc,2023-24,NCD,NCD,NCDMI025,Vaccination & Immunisation,NCD,0,FI,NCDMI025,Percentage of patients in long stay residential or homes who received a seasonal influenza vaccination between 1 September and 31 March.,Exclusion,CARHOME_18,CARHOME_18,n/a,n/a,n/a,CARHOME_18
tbc,2023-24,NCD,NCD,NCDMI025,Vaccination & Immunisation,NCD,0,FI,NCDMI025,Percentage of patients in long stay residential or homes who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUINVITE1,FLUINVITE1,n/a,n/a,n/a,FLUINVITE1
tbc,2023-24,NCD,NCD,NCDMI061,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI061,"Percentage of patients aged 25 to 84 years inclusive and with a last recorded CVD risk score (QRISK2 or 3) greater than or equal to 10 percent, who are currently treated with statins.",PCA,CHOLMX_DAT,CHOLMX_DAT,n/a,n/a,n/a,CHOLMX_DAT
tbc,2023-24,NCD,NCD,NCDMI068,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI068,Mean number of structured medication reviews undertaken per registered patient.,PCA,STRMEDRVDC,STRMEDRVDC,n/a,n/a,n/a,STRMEDRVDC
tbc,2023-24,NCD,NCD,NCDMI101,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI101,"Percentage of patients aged 65 years or over and who received a blood pressure check, who received a pulse check",Exclusion,PAT_AGEU65,PAT_AGEU65,n/a,n/a,n/a,PAT_AGEU65
tbc,2023-24,NCD,NCD,NCDMI123,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI123,Percentage of patients aged 18 years or over with an eGFR less than 45 who were prescribed an oral non-steroidal anti-inflammatory drug (NSAID).,Exclusion,EGFRB3ML45,EGFRB3ML45,n/a,n/a,n/a,EGFRB3ML45
tbc,2023-24,NCD,NCD,NCDMI123,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI123,Percentage of patients aged 18 years or over with an eGFR less than 45 who were prescribed an oral non-steroidal anti-inflammatory drug (NSAID).,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI137,Tackling Health Inequalities,NCD,0,FI,NCDMI137,Number of patients recorded as having a diagnosis of autism,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI174,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI174,Percentage of patients aged 18 years or over prescribed lithium for at least 3 months without a lithium concentration check in the previous 3 months.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI175,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI175,Percentage of patients aged 18 years or over prescribed amiodarone for at least 6 months without a thyroid function test (TFT) in the previous 6 months.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI182,Tackling Health Inequalities,NCD,0,FI,NCDMI182,"Percentage of patients on the QOF Learning Disability register aged 14 years or over, who received an annual Learning Disability Health Check and a completed Health Action Plan.",Exclusion,LD_DAT,LD_DAT,n/a,n/a,n/a,LD_DAT
tbc,2023-24,NCD,NCD,NCDMI199,Vaccination & Immunisation,NCD,0,FI,NCDMI199,"Percentage of patients aged 65 years or over, who received a seasonal influenza vaccination between 1 September and 31 March.",PCA,FLUEXPCON,FLUEXPCON,n/a,n/a,n/a,FLUEXPCON
tbc,2023-24,NCD,NCD,NCDMI200,Tackling Health Inequalities,NCD,0,FI,NCDMI200,Percentage of registered patients with a recording of ethnicity.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI200,Tackling Health Inequalities,NCD,0,FI,NCDMI200,Percentage of registered patients with a recording of ethnicity.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD003,Vaccination & Immunisation,NCD,0,FI,NCD003,Percentage of at-risk patients aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUEXPCON,FLUEXPCON,n/a,n/a,n/a,FLUEXPCON
tbc,2023-24,NCD,NCD,NCD011,Cardiovascular Disease Prevention,NCD,0,FI,NCD011,"Percentage of patients aged 18 years or over, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90mmHg (with the exception of patients whose first blood pressure reading >= 140/90mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",PCA,ABPDEC24M,ABPDEC24M,n/a,n/a,n/a,ABPDEC24M
tbc,2023-24,NCD,NCD,NCDMI025,Vaccination & Immunisation,NCD,0,FI,NCDMI025,Percentage of patients in long stay residential or homes who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUEXPCON,FLUEXPCON,n/a,n/a,n/a,FLUEXPCON
tbc,2023-24,NCD,NCD,NCDMI027,Vaccination & Immunisation,NCD,0,FI,NCDMI027,"Percentage of patients on the QOF Mental Health register for schizophrenia, bipolar affective disorder and other psychoses and either aged 65 years or over, or aged between 18 and 64 years inclusive and in a clinical at-risk group, who received a seasonal influenza vaccination between 1 September and 31 March.",Exclusion,MH_MHREM,MH_MHREM,n/a,n/a,n/a,MH_MHREM
tbc,2023-24,NCD,NCD,NCDMI112,Enhanced Health in Care Homes,NCD,0,FI,NCDMI112,Percentage of care home residents aged 18 years or over on the QOF Dementia Register.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI123,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI123,Percentage of patients aged 18 years or over with an eGFR less than 45 who were prescribed an oral non-steroidal anti-inflammatory drug (NSAID).,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI129,Tackling Health Inequalities,NCD,0,FI,NCDMI129,Percentage of at-risk patients recorded as being from an ethnic minority and aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March,PCA,FLUEXPCON,FLUEXPCON,n/a,n/a,n/a,FLUEXPCON
tbc,2023-24,NCD,NCD,NCDMI133,Tackling Health Inequalities,NCD,0,FI,NCDMI133,Percentage of patients aged 45 or over and recorded as being from an ethnic minority who have a record of blood pressure in the preceding 5 years,PCA,REGL3M_DAT,REGL3M_DAT,n/a,n/a,n/a,REGL3M_DAT
tbc,2023-24,NCD,NCD,NCDMI142,Workforce,NCD,0,FI,NCDMI142,"Number of encounters with a Physician Associate, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD004,Vaccination & Immunisation,NCD,0,FI,NCD004,Percentage of patients aged two or three years on 31 August of the relevant financial year who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,XFLU_DAT,XFLU_DAT,n/a,n/a,n/a,XFLU_DAT
tbc,2023-24,NCD,NCD,NCD107,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD107,"Percentage of patients aged 18 years or over prescribed both a Non-Steroidal Anti-Inflammatory Drug (NSAID) and an oral anticoagulant in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an NSAID or (ii) prescribed a gastro-protective in addition to an NSAID.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCD123,Cancer,NCD,0,FI,NCD123,"Percentage of lower gastrointestinal two week wait (fast track) cancer referrals accompanied by a faecal immunochemical test result, with the result recorded in the twenty-one days leading up to the referral.",PCA,FITNIDAT,FITNIDAT,n/a,n/a,n/a,FITNIDAT
tbc,2023-24,NCD,NCD,NCDMI002,Personalised Care,NCD,0,FI,NCDMI002,Percentage of registered patients who had a Personalised Care and Support Plan reviewed.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI028,Tackling Health Inequalities,NCD,0,FI,NCDMI028,Percentage of patients aged 14 years or over and on the QOF Learning Disability Register who received a Learning Disability Annual Health Check.,Exclusion,LD_DAT,LD_DAT,n/a,n/a,n/a,LD_DAT
tbc,2023-24,NCD,NCD,NCDMI028,Tackling Health Inequalities,NCD,0,FI,NCDMI028,Percentage of patients aged 14 years or over and on the QOF Learning Disability Register who received a Learning Disability Annual Health Check.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI063,Personalised Care,NCD,0,FI,NCDMI063,Percentage of registered patients currently being seen by a social prescribing service.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI112,Enhanced Health in Care Homes,NCD,0,FI,NCDMI112,Percentage of care home residents aged 18 years or over on the QOF Dementia Register.,Exclusion,NURSHOME,NURSHOME,n/a,n/a,n/a,NURSHOME
tbc,2023-24,NCD,NCD,NCDMI120,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI120,"Percentage of patients aged 18 years or over prescribed an oral anticoagulant and an anti-platelet, who were not prescribed a gastro-protective.",Exclusion,ANTICOAG3M,ANTICOAG3M,n/a,n/a,n/a,ANTICOAG3M
tbc,2023-24,NCD,NCD,NCDMI121,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI121,"Percentage of patients aged 18 years or over prescribed aspirin and another anti-platelet, who were not prescribed a gastro-protective.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI129,Tackling Health Inequalities,NCD,0,FI,NCDMI129,Percentage of at-risk patients recorded as being from an ethnic minority and aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March,Exclusion,P_AGE18_64,P_AGE18_64,n/a,n/a,n/a,P_AGE18_64
tbc,2023-24,NCD,NCD,NCDMI129,Tackling Health Inequalities,NCD,0,FI,NCDMI129,Percentage of at-risk patients recorded as being from an ethnic minority and aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March,PCA,XFLU_DAT,XFLU_DAT,n/a,n/a,n/a,XFLU_DAT
tbc,2023-24,NCD,NCD,NCDMI134,Tackling Health Inequalities,NCD,0,FI,NCDMI134,"Percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who received all six elements of the Physical Health Check for people with Severe Mental Illness.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI163,Workforce,NCD,0,FI,NCDMI163,Percentage of registered patients who had at least one encounter with a Paramedic.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI167,Enhanced Health in Care Homes,NCD,0,FI,NCDMI167,Percentage of permanent care home residents aged 18 years or over who received a falls risk assessment.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI188,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI188,Percentage of patients using potentially addictive medicines who received a Structured Medication Review.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI205,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI205,"Percentage of patients on the QOF Coronary Heart Disease, Peripheral Arterial Disease, or Stroke/TIA Register, who have a recording of non-HDL cholesterol in the preceding 12 months that is lower than 2.5 mmol/L, or where non-HDL cholesterol is not recorded then  a recording of LDL cholesterol in the preceding 12 months that is lower than 1.8 mmol/L.",PCA,CHOLDEC,CHOLDEC,n/a,n/a,n/a,CHOLDEC
tbc,2023-24,NCD,NCD,NCD011,Cardiovascular Disease Prevention,NCD,0,FI,NCD011,"Percentage of patients aged 18 years or over, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90mmHg (with the exception of patients whose first blood pressure reading >= 140/90mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Exclusion,HYPLATUNR,HYPLATUNR,n/a,n/a,n/a,HYPLATUNR
tbc,2023-24,NCD,NCD,NCD014,Environmental Sustainability,NCD,0,FI,NCD014,Metered Dose Inhaler (MDI) prescriptions as a percentage of all non-salbutamol inhaler prescriptions issued to patients aged 12 years or over.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI023,Early Cancer Diagnosis,NCD,0,FI,NCDMI023,Percentage of patients who were placed on an urgent referral pathway for suspected cancer.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI027,Vaccination & Immunisation,NCD,0,FI,NCDMI027,"Percentage of patients on the QOF Mental Health register for schizophrenia, bipolar affective disorder and other psychoses and either aged 65 years or over, or aged between 18 and 64 years inclusive and in a clinical at-risk group, who received a seasonal influenza vaccination between 1 September and 31 March.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI061,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI061,"Percentage of patients aged 25 to 84 years inclusive and with a last recorded CVD risk score (QRISK2 or 3) greater than or equal to 10 percent, who are currently treated with statins.",PCA,STATINTOL,STATINTOL,n/a,n/a,n/a,STATINTOL
tbc,2023-24,NCD,NCD,NCDMI122,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI122,Percentage of patients aged 18 years or over with heart failure who were prescribed an oral non-steroidal anti-inflammatory drug (NSAID).,Exclusion,HFRESLAT,HFRESLAT,n/a,n/a,n/a,HFRESLAT
tbc,2023-24,NCD,NCD,NCDMI126,Anticipatory Care,NCD,0,FI,NCDMI126,Percentage of registered patients who declined an offer of Anticipatory Care,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI160,Workforce,NCD,0,FI,NCDMI160,"Number of encounters with a Nursing Associate, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI176,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI176,"Percentage of patients aged 25 to 84 years inclusive without established cardiovascular disease and with a last recorded CVD risk score (QRISK2 or 3) greater than 20 percent, who are currently treated with statins.",PCA,STATDECAW,STATDECAW,n/a,n/a,n/a,STATDECAW
tbc,2023-24,NCD,NCD,NCDMI180,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI180,Percentage of patients at risk of harm due to medication errors who received a Structured Medication Review.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI182,Tackling Health Inequalities,NCD,0,FI,NCDMI182,"Percentage of patients on the QOF Learning Disability register aged 14 years or over, who received an annual Learning Disability Health Check and a completed Health Action Plan.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI189,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI189,"Percentage of permanent care home residents aged 18 years or over, who received a Structured Medication Review.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD004,Vaccination & Immunisation,NCD,0,FI,NCD004,Percentage of patients aged two or three years on 31 August of the relevant financial year who received a seasonal influenza vaccination between 1 September and 31 March.,PCA,FLUDEC_DAT,FLUDEC_DAT,n/a,n/a,n/a,FLUDEC_DAT
tbc,2023-24,NCD,NCD,NCD102,Cardiovascular Disease Prevention,NCD,0,FI,NCD102,Percentage of patients aged 29 and under with a total cholesterol greater than 7.5mmol/L OR aged 30 and over with a total cholesterol greater than 9.0mmol/L who have been either: (i) diagnosed with secondary hyperlipidaemia; (ii) clinically assessed for familial hypercholesterolaemia; (iii) referred for assessment for familial hypercholesterolemia; or (iv) genetically diagnosed with familial hypercholesterolaemia.,PCA,PALCARDAT2,PALCARDAT2,n/a,n/a,n/a,PALCARDAT2
tbc,2023-24,NCD,NCD,NCD110,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD110,"Percentage of patients aged 18 years or over prescribed aspirin and another anti-platelet in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed aspirin and/or no longer prescribed an anti-platelet or (ii) prescribed a gastro-protective in addition to both aspirin and another anti-platelet.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCD117,Cardiovascular Disease Prevention,NCD,0,FI,NCD117,"Percentage of men aged 50 years or over and women aged 55 years or over, without established Cardiovascular Disease and not on lipid lowering therapy, who have a QRISK score recorded on their GP record in the preceding five years and who have a recording of cholesterol levels, blood pressure and smoking status in the 12 months preceding recording of the most recent QRISK score",PCA,DECTESTQR,DECTESTQR,n/a,n/a,n/a,DECTESTQR
tbc,2023-24,NCD,NCD,NCDMI003,Personalised Care,NCD,0,FI,NCDMI003,Percentage of registered patients whose care has been discussed as part of a shared decision-making process.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI010,Enhanced Health in Care Homes,NCD,0,FI,NCDMI010,"Percentage of permanent care home residents aged 18 years or over, and recorded as experiencing acute confusion, who received a delirium assessment.",Exclusion,HOMECONF18,HOMECONF18,n/a,n/a,n/a,HOMECONF18
tbc,2023-24,NCD,NCD,NCDMI108,Personalised Care,NCD,0,FI,NCDMI108,Number of General Practitioner consultations per registered patient.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI118,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI118,"Percentage of patients aged 18 years or over with a history of peptic ulceration and prescribed an anti-platelet, who were not prescribed a gastro-protective",Exclusion,PEPULCB3M,PEPULCB3M,n/a,n/a,n/a,PEPULCB3M
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",PCA,BPLAT6M,BPLAT6M,n/a,n/a,n/a,BPLAT6M
tbc,2023-24,NCD,NCD,NCDMI133,Tackling Health Inequalities,NCD,0,FI,NCDMI133,Percentage of patients aged 45 or over and recorded as being from an ethnic minority who have a record of blood pressure in the preceding 5 years,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI138,Workforce,NCD,0,FI,NCDMI138,"Number of encounters with a Clinical Pharmacist, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI160,Workforce,NCD,0,FI,NCDMI160,"Number of encounters with a Nursing Associate, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD102,Cardiovascular Disease Prevention,NCD,0,FI,NCD102,Percentage of patients aged 29 and under with a total cholesterol greater than 7.5mmol/L OR aged 30 and over with a total cholesterol greater than 9.0mmol/L who have been either: (i) diagnosed with secondary hyperlipidaemia; (ii) clinically assessed for familial hypercholesterolaemia; (iii) referred for assessment for familial hypercholesterolemia; or (iv) genetically diagnosed with familial hypercholesterolaemia.,Exclusion,NOCHOL2930,NOCHOL2930,n/a,n/a,n/a,NOCHOL2930
tbc,2023-24,NCD,NCD,NCD110,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD110,"Percentage of patients aged 18 years or over prescribed aspirin and another anti-platelet in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed aspirin and/or no longer prescribed an anti-platelet or (ii) prescribed a gastro-protective in addition to both aspirin and another anti-platelet.",Exclusion,NOPQSSAL,NOPQSSAL,n/a,n/a,n/a,NOPQSSAL
tbc,2023-24,NCD,NCD,NCD123,Cancer,NCD,0,FI,NCD123,"Percentage of lower gastrointestinal two week wait (fast track) cancer referrals accompanied by a faecal immunochemical test result, with the result recorded in the twenty-one days leading up to the referral.",PCA,FAECIMMDEC,FAECIMMDEC,n/a,n/a,n/a,FAECIMMDEC
tbc,2023-24,NCD,NCD,NCDMI028,Tackling Health Inequalities,NCD,0,FI,NCDMI028,Percentage of patients aged 14 years or over and on the QOF Learning Disability Register who received a Learning Disability Annual Health Check.,PCA,HLTHCHKDEC,HLTHCHKDEC,n/a,n/a,n/a,HLTHCHKDEC
tbc,2023-24,NCD,NCD,NCDMI063,Personalised Care,NCD,0,FI,NCDMI063,Percentage of registered patients currently being seen by a social prescribing service.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI167,Enhanced Health in Care Homes,NCD,0,FI,NCDMI167,Percentage of permanent care home residents aged 18 years or over who received a falls risk assessment.,Exclusion,CARHOMNP18,CARHOMNP18,n/a,n/a,n/a,CARHOMNP18
tbc,2023-24,NCD,NCD,NCDMI198,Enhanced Health in Care Homes,NCD,0,FI,NCDMI198,Mean number of patient contacts as part of weekly care home round per care home resident aged 18 years and over.,PCA,CARHOMDEC1,CARHOMDEC1,n/a,n/a,n/a,CARHOMDEC1
tbc,2023-24,NCD,NCD,NCD109,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCD109,"Percentage of patients aged 18 years or over prescribed both an oral anticoagulant and an anti-platelet in the last 3 months of the previous financial year, who, in the three months to the end of the reporting period, were either (i) no longer prescribed an anti-platelet or (ii) prescribed a gastro-protective in addition to an anti-platelet.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI028,Tackling Health Inequalities,NCD,0,FI,NCDMI028,Percentage of patients aged 14 years or over and on the QOF Learning Disability Register who received a Learning Disability Annual Health Check.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI068,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI068,Mean number of structured medication reviews undertaken per registered patient.,PCA,PALCARDAT2,PALCARDAT2,n/a,n/a,n/a,PALCARDAT2
tbc,2023-24,NCD,NCD,NCDMI101,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI101,"Percentage of patients aged 65 years or over and who received a blood pressure check, who received a pulse check",Exclusion,NOBP_DAT,NOBP_DAT,n/a,n/a,n/a,NOBP_DAT
tbc,2023-24,NCD,NCD,NCDMI175,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI175,Percentage of patients aged 18 years or over prescribed amiodarone for at least 6 months without a thyroid function test (TFT) in the previous 6 months.,Exclusion,NOAMIO12M,NOAMIO12M,n/a,n/a,n/a,NOAMIO12M
tbc,2023-24,NCD,NCD,NCDMI178,Respiratory Care,NCD,0,FI,NCDMI178,Percentage of patients on the QOF asthma register who received 6 or more Short Acting Beta-2 Agonist (SABA) inhaler prescriptions over the previous 12 months.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI189,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI189,"Percentage of permanent care home residents aged 18 years or over, who received a Structured Medication Review.",Exclusion,CARHOMNP18,CARHOMNP18,n/a,n/a,n/a,CARHOMNP18
tbc,2023-24,NCD,NCD,NCDMI199,Vaccination & Immunisation,NCD,0,FI,NCDMI199,"Percentage of patients aged 65 years or over, who received a seasonal influenza vaccination between 1 September and 31 March.",PCA,FLUDEC_DAT,FLUDEC_DAT,n/a,n/a,n/a,FLUDEC_DAT
tbc,2023-24,NCD,NCD,NCDMI064,Personalised Care,NCD,0,FI,NCDMI064,"Percentage of patients with a long-term condition, whose care was discussed as part of a shared decision-making conversation.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI127,Anticipatory Care,NCD,0,FI,NCDMI127,Percentage of registered patients discharged from Anticipatory Care service,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI129,Tackling Health Inequalities,NCD,0,FI,NCDMI129,Percentage of at-risk patients recorded as being from an ethnic minority and aged 18 to 64 years inclusive who received a seasonal influenza vaccination between 1 September and 31 March,PCA,FLUINVITE1,FLUINVITE1,n/a,n/a,n/a,FLUINVITE1
tbc,2023-24,NCD,NCD,NCDMI140,Workforce,NCD,0,FI,NCDMI140,"Number of encounters with a First Contact Physiotherapist, per registered patient.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI150,Workforce,NCD,0,FI,NCDMI150,"Number of encounters with an Occupational Therapist, per registered patient.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI151,Workforce,NCD,0,FI,NCDMI151,Percentage of registered patients who had at least one encounter with an Occupational Therapist.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI199,Vaccination & Immunisation,NCD,0,FI,NCDMI199,"Percentage of patients aged 65 years or over, who received a seasonal influenza vaccination between 1 September and 31 March.",Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI076,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI076,Percentage of registered patients prescribed benzodiazepines.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI114,Enhanced Health in Care Homes,NCD,0,FI,NCDMI114,Mean number of Multidisciplinary Team meetings per care home resident aged 18 years or over.,Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI103,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI103,Percentage of patients aged 65 years or over and with an irregular pulse who either received an electrocardiogram or were referred for an electrocardiogram.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI131,Tackling Health Inequalities,NCD,0,FI,NCDMI131,Percentage of patients aged 16 years or over and recorded as being from an ethnic minority who have received a second dose of a Covid 19 vaccination,PCA,C19DEC_DAT,C19DEC_DAT,n/a,n/a,n/a,C19DEC_DAT
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI134,Tackling Health Inequalities,NCD,0,FI,NCDMI134,"Percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who received all six elements of the Physical Health Check for people with Severe Mental Illness.",PCA,SMOKORDEC,SMOKORDEC,n/a,n/a,n/a,SMOKORDEC
tbc,2023-24,NCD,NCD,NCDMI135,Tackling Health Inequalities,NCD,0,FI,NCDMI135,"Percentage of patients with schizophrenia, bipolar affective disorder and other psychoses and recorded as being from an ethnic minority who received all six elements of the Physical Health Check for people with Severe Mental Illness",PCA,SMOKORDEC,SMOKORDEC,n/a,n/a,n/a,SMOKORDEC
tbc,2023-24,NCD,NCD,NCDMI173,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI173,Percentage of patients aged 18 years or over prescribed methotrexate for at least 3 months without a liver function test in the previous 3 months.,Exclusion,NOMETH3M6M,NOMETH3M6M,n/a,n/a,n/a,NOMETH3M6M
tbc,2023-24,NCD,NCD,NCDMI178,Respiratory Care,NCD,0,FI,NCDMI178,Percentage of patients on the QOF asthma register who received 6 or more Short Acting Beta-2 Agonist (SABA) inhaler prescriptions over the previous 12 months.,Exclusion,ASTRES_DAT,ASTRES_DAT,n/a,n/a,n/a,ASTRES_DAT
tbc,2023-24,NCD,NCD,NCDMI155,Workforce,NCD,0,FI,NCDMI155,Percentage of registered patients who had at least one encounter with a Health and Wellbeing Coach.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI124,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI124,Percentage of patients aged 18 years or over with an unresolved asthma diagnosis who were prescribed a non-selective beta-blocker.,Exclusion,ASTB3M_DAT,ASTB3M_DAT,n/a,n/a,n/a,ASTB3M_DAT
tbc,2023-24,NCD,NCD,NCDMI165,Workforce,NCD,0,FI,NCDMI165,Percentage of registered patients who had at least one encounter with a Mental Health Practitioner.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD113,Access,NCD,0,FI,NCD113,Number of referrals to the Community Pharmacist Consultation Service per registered patient,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI061,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI061,"Percentage of patients aged 25 to 84 years inclusive and with a last recorded CVD risk score (QRISK2 or 3) greater than or equal to 10 percent, who are currently treated with statins.",Exclusion,P_AGE25_84,P_AGE25_84,n/a,n/a,n/a,P_AGE25_84
tbc,2023-24,NCD,NCD,NCDMI106,Personalised Care,NCD,0,FI,NCDMI106,Number of General Practitioner consultations per patient currently being seen by a social prescribing service.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI114,Enhanced Health in Care Homes,NCD,0,FI,NCDMI114,Mean number of Multidisciplinary Team meetings per care home resident aged 18 years or over.,PCA,CARHOMDEC1,CARHOMDEC1,n/a,n/a,n/a,CARHOMDEC1
tbc,2023-24,NCD,NCD,NCDMI147,Workforce,NCD,0,FI,NCDMI147,Percentage of registered patients who had at least one encounter with a Podiatrist.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCD123,Cancer,NCD,0,FI,NCD123,"Percentage of lower gastrointestinal two week wait (fast track) cancer referrals accompanied by a faecal immunochemical test result, with the result recorded in the twenty-one days leading up to the referral.",Exclusion,GICANREF,GICANREF,n/a,n/a,n/a,GICANREF
tbc,2023-24,NCD,NCD,NCDMI172,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI172,Percentage of patients aged 18 years or over prescribed methotrexate for at least 3 months without a full blood count in the previous 3 months.,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI109,Personalised Care,NCD,0,FI,NCDMI109,Number of consultations per patient currently being seen by a social prescribing service.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI132,Tackling Health Inequalities,NCD,0,FI,NCDMI132,"Percentage of patients aged 18 years or over, recorded as being from an ethnic minority, not on the QOF Hypertension Register as of 31 March 2023, and who have (i) a last recorded blood pressure reading in the 3 years prior to 1 April 2023 >= 140/90 mmHg (with the exception of patients whose first blood pressure reading >= 140/90 mmHg in this period is on or after 1 October 2022) for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension by 31 March 2024 OR (ii) a blood pressure reading >= 140/90mmHg on or after 1 October 2022, for whom there is evidence of clinically appropriate follow-up to confirm or exclude a diagnosis of hypertension within 6 months of elevated reading.",PCA,ABPDEC12M,ABPDEC12M,n/a,n/a,n/a,ABPDEC12M
tbc,2023-24,NCD,NCD,NCD014,Environmental Sustainability,NCD,0,FI,NCD014,Metered Dose Inhaler (MDI) prescriptions as a percentage of all non-salbutamol inhaler prescriptions issued to patients aged 12 years or over.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI010,Enhanced Health in Care Homes,NCD,0,FI,NCDMI010,"Percentage of permanent care home residents aged 18 years or over, and recorded as experiencing acute confusion, who received a delirium assessment.",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI119,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI119,"Percentage of patients aged 18 years or over prescribed an oral anticoagulant, who were prescribed an oral NSAID.",Exclusion,ANTICOAG3M,ANTICOAG3M,n/a,n/a,n/a,ANTICOAG3M
tbc,2023-24,NCD,NCD,NCDMI117,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI117,"Percentage of patients aged 18 years or over with a history of peptic ulceration and prescribed an oral non-steroidal anti-inflammatory drug (NSAID), who were not prescribed a gastro-protective.",Exclusion,PAT_AGEU18,PAT_AGEU18,n/a,n/a,n/a,PAT_AGEU18
tbc,2023-24,NCD,NCD,NCDMI170,Enhanced Health in Care Homes,NCD,0,FI,NCDMI170,Percentage of permanent care home residents aged 18 years or over who received a psychosocial assessment,Denominator,Denominator,Denominator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI170,Enhanced Health in Care Homes,NCD,0,FI,NCDMI170,Percentage of permanent care home residents aged 18 years or over who received a psychosocial assessment,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI181,Structured Medication Reviews & Medicines Optimisation,NCD,0,FI,NCDMI181,Percentage of patients living with severe frailty who received a Structured Medication Review.,PCA,PALCARDAT2,PALCARDAT2,n/a,n/a,n/a,PALCARDAT2
tbc,2023-24,NCD,NCD,NCD120,Tackling Health Inequalities,NCD,0,FI,NCD120,"Percentage of patients on the QOF Learning Disability register aged 14 or over, who received an annual Learning Disability Health Check and have a completed Health Action Plan, in addition to a recording of ethnicity.",Exclusion,LD_DAT,LD_DAT,n/a,n/a,n/a,LD_DAT
tbc,2023-24,NCD,NCD,NCDMI101,Cardiovascular Disease Prevention,NCD,0,FI,NCDMI101,"Percentage of patients aged 65 years or over and who received a blood pressure check, who received a pulse check",Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI167,Enhanced Health in Care Homes,NCD,0,FI,NCDMI167,Percentage of permanent care home residents aged 18 years or over who received a falls risk assessment.,PCA,CARHOMDEC1,CARHOMDEC1,n/a,n/a,n/a,CARHOMDEC1
tbc,2023-24,NCD,NCD,NCDMI149,Workforce,NCD,0,FI,NCDMI149,Percentage of registered patients who had at least one encounter with a Pharmacy Technician.,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
tbc,2023-24,NCD,NCD,NCDMI125,Anticipatory Care,NCD,0,FI,NCDMI125,Percentage of registered patients under the care of Anticipatory Care service,Numerator,Numerator,Numerator,n/a,n/a,n/a,n/a
